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Abstract
With the rapid increase in the volume of genomic and transcript data in mouse
and human, a diverse set of alternative splicing patterns can be discovered. We
have set out to explore in more depth some of these unique splicing patterns which
include: i.) tandem acceptor splice sites termed ’NAGNAGs’, which cause an exon
length variation of three nucleotides, ii.) the splicing of internal cassette exons,
whose inclusion and exclusion are strongly associated with their transcriptional start
sites, iii.) and groups of internal cassette exons that are always observed to be
either included or excluded together within a transcript. We did not find much
evidence of functional potential for the majority of variant acceptor splice sites
carrying the NAGNAG motif and thus conclude that their abundance is due mostly
to the stochastic behaviour of the spliceosome. We inferred that a large fraction
(15-30%) of internal cassette exons in transcription units with multiple start sites
are included and skipped in a transcription-start-site-dependent manner. We did
not find that this relationship is conserved in orthologous human and mouse exons.
Our first analysis has revealed several interesting trends in mutually dependent
exons when compared to mutually exclusive and constitutive exons: these exons
have a stronger pressure to maintain the reading frame as a group of exons rather
than individually, and they generally have shorter intron lengths. Ours are the
first analyses of transcription-start-site-dependent and mutually-dependent splicing.
Their mechanisms remain to be further elucidated and our results provide a good
starting point for future computational and experimental studies.
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Chapter 1
Introduction
1.1 What is alternative splicing?
Splicing is an mRNA processing step whereby introns are removed from the pre-
mRNA and exons are ligated to form the mature mRNA. The molecular tool re-
sponsible for removal of introns is a ribonucleoprotein complex called the spliceo-
some. The active spliceosome consists of five small nuclear ribonucleoprotein par-
ticles (snRNPs) that are associated with a large number of splicing factors. The
spliceosome generally recognizes oligonucleotide sequences as well as splice sites
(donor and acceptor) which are found at the ends of the intron and are highly con-
served throughout eukaryotes. How the spliceosome specifically selects a particular
splice site depends on several factors which will be discussed in section 1.2. The
usage of a particular donor splice site may be used in conjunction with different
acceptor splice sites and vice versa, which may result in different variants of the
gene.
The initial steps of splicing are depicted in Fig. 1.1. The process begins with the
positioning and rearrangement of splicing factors on the pre-mRNA, which eventu-
ally leads to the assembly of an active spliceosome that carries out intron removal.
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Figure 1.1: Mammalian spliceosomal assembly. The assembly of the spliceosome begins with
the assembly of five small nuclear ribonucleoprotein particles (snRNPs) - U1, U2, U4, U5, and U6,
in which these snRNPs associate with other proteins. The H-complex consists of pre-mRNAs
associating with heterogeneous nuclear ribonucleoproteins (hnRNPs). In the E-complex, all the
consensus splice-site signals are recognized - U1 snRNP binds to the 5’ splice site, splicing factor 1
(SF1) binds to the branch point, the large and small subunits of U2 auxiliary factor(U2AF) bind
to the polypyrimidine tract and acceptor splice site respectively, and lastly serine-arginine proteins
(SRp) bind to exonic splicing enhancers, U2AF, U1 snRNP, and the branch point. Spliceosomal
assemblies across the intron and exon are shown for E and A complexes, however, assembly across
the intron must occur before the assembly of the active spliceosome. The formation of the A-
complex results from ATP hydrolysis, during which the U2 snRNP binds to the branch point and
the 3’ splice-site sequence. The B-complex and the final catalytic complex are formed through
the incorporation and rearrangements of the tri-snRNPs (U4,U5, and U6). Figure extracted from
Matlin et al. [1].
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The splicing reaction is essentially a chemical reaction. The chemistry of intron
removal and exon ligation occurs via two transesterification reactions as illustrated
in Fig.1.2.
Figure 1.2: The chemistry of the splicing reaction. During the first transesterification
reaction, the 2’ oxygen of the adenosine residue (at the branch point) forms a bond with the
phosphorus atom at the donor splice site, resulting in a lasso structure between the 5’ end of the
intron and 3’ exon. The oxygen atom at the 3’ hydroxyl group of the 5’ exon then forms a bond
with the phosphorus atom at the acceptor splice site, thus resulting in the ligation of exons and
excision of the lariat intron. Figure extracted from Brow, D. [2].
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1.2 Factors affecting alternative splice-site choice
The selection of different splice sites can generate different alternative splicing pat-
terns as illustrated in Fig. 1.3. The frequency of occurrence of these splicing patterns
varies across species, with exon skipping being most frequent in mammalians and
intron-retention occurring most frequently in plants [1].
Figure 1.3: The different types of alternative splicing. The term ’cassette exons’ describes
exons that are skipped in some transcripts and included in others (Ba). Mutually exclusive exons
are alternative exons that are never included or excluded together in the same transcript (Bb).
Competing donor (Bc) and acceptor splice sites (Bd) result in exon-length variations from the donor
and acceptor splice sites respectively. Intron retention (Be) is when the intron is not removed and is
present within the mature transcript. The usage of alternative promoters (Bf) and polyadenylation
sites (Bg) can result in different transcript variants. Figure extracted from Matlin et al. [1].
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The actual mechanisms for splice-site selection may vary from gene to gene, but
they typically involve repressing or enhancing the use of specific alternative splice-
sites through recruitment of competing splicing factors and usage of inhibitory or
enhancing regulatory elements. In essence, as said by Franciso Baralle [3] ”it is
the fine balance of power between a myriad of controlling factors” that determines
the final splicing decision. These splice-site enhancing or repressing factors and
sequences that they bind are described in the following subsections.
1.2.1 Splicing regulatory elements
Splicing regulatory elements are classified into two types: enhancer and silencer el-
ements, both of which can be found in introns and exons. As their name implies,
splicing enhancer and silencer elements are bound by factors that enhance or re-
press respectively, the usage of a particular splice site. Some examples of different
enhancer and silencer elements affecting the usage of splice sites are tabulated in
Table 1.1.
May 30, 2008
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1.2.2 Concentration of splicing factors
The splicing regulatory elements mentioned previously can be bound by both splicing
factors such as SR proteins and heterogeneous nuclear ribonucleoproteins (hnRNPs).
It is known that the activity of SF2/ASF can be antagonized by hnRNPA1 [8, 9]
and it has been shown that the relative concentrations of these antagonistic splicing
factors can influence the outcome of splice events. Caceres et al. [10] have shown
that over-expression of SF2/ASF activates the usage of proximal donor splice sites,
and promotes inclusion of a neuron-specific exon, whereas increased expression of
hnRNP A1 promotes the usage of distal donor splice sites. Hanamura et al. [11]
have suggested that the alternative splicing of specific transcripts may be subjected
to different levels of hnRNP A/B and SR proteins, but at present - one cannot
determine which and how many transcripts are differentially spliced as a consequence
of variable concentrations of these splicing factors.
1.2.3 Dual functions of splicing factors
Some splicing factors can function as both activators and repressors. Recently, the
hnRNP M protein has been shown to promote the exclusion of the FGFR2-IIIb exon
presumably by binding to the ISS flanking this exon. On the other hand, hnRNP M
promotes the inclusion of a troponin-derived exon flanked by muscle-specific ISEs
[12]. Other splicing regulators such as Nova-1 [13], Fox-1 [14], the CELF protein
family [15], and hnRNPL [16] have also been shown to promote exon inclusion and
exclusion.
1.2.4 Splice-site strengths
Constitutive exons usually have stronger splice-site signals when compared to their
alternative exons, which suggest that alternative exons can be more easily regu-
lated than their constitutive exons [17]. Evidence from literature have shown that
strengthening of a weak donor splice site results in exon 4 inclusion of the rat
preprotachykinin gene (encodes a neuropeptide) [18]. The polypyrimidine tract is
important for efficient branch point usage and acceptor splice-site recognition and
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its mutation leads to either increased or decreased splice-site strength. For instance,
Dominski and Kole [19] have demonstrated that exon skipping is reversed when the
strength of the polypyrimidine tract have been increased. The strength of the splice
sites flanking cassette exons also influences its responsiveness to transcriptional elon-
gation, whereby Nogues et al. [20] have observed that weaker acceptor splice sites
flanking the fibronectin extra domain I exon, increases its responsiveness to the rate
of elongation of the RNA polymerase.
1.2.5 Exon- and intron-length
Although, the exon- and intron-lengths do not directly affect alternative splicing,
size constraints imposed by interactions between splicing factors do exist. Sterner
et al. [21] investigated the relationship between intron and exon size in pre-mRNA
processing and have found that splicing became problematic when intron and exon
sizes exceeded 500 nucleotides. Furthermore, his findings has revealed an inverse
relationship between exon and intron size. Small exons are efficiently included when
flanked by large introns. As the exon size increases, they are less efficiently included
when flanked by large introns, but are included when the intron size decreases.
1.2.6 Impact of RNA secondary structure on alternative
splicing
Despite the unavailability of experimental pre-mRNA secondary structures, there
has been an increase in the observations of highly conserved complementary se-
quences that can form putative RNA secondary structures surrounding alternative
exons, thereby suggesting that RNA secondary structure formation is a likely mech-
anism for influencing alternative splicing events.
Models of how RNA secondary structures can affect splicing have been put forth
by Buratti and Baralle [22]. They proposed that if RNA secondary structures did
form in splicing factor binding sites, such as exon-intron junctions and splicing
regulatory elements - this would affect the proper binding of splicing factors and
thus influence the downstream splicing events.
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An example of putative RNA secondary structures regulating the splicing of the
Drosophila homothorax gene (hth) is illustrated in Figure 1.4.
Figure 1.4: Alternative RNA secondary structures formed by the conserved elements
of the hth gene. Alternative splicing of the hth gene involves partial intron retention of the
intron between exon 6 and 7, which occurs when the donor splice site flanking exon 6 is not used.
The figure shows proposed RNA secondary structures that can either block U1 snRNP binding to
the donor splice site (left RNA secondary structure) or allow accessibility at the donor splice site
of exon 6. The ultraconserved elements, A and B, can base-pair with each other to form an RNA
hairpin structure or base-pair with another downstream conserved pair of elements (A′ and B′) to
form another RNA hairpin. Figure extracted from Glazov et al. [23].
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1.3 Consequences of alternative splicing
1.3.1 A diversity of molecular properties of proteins and
mRNAs arising from alternative splicing
Alternative splicing can lead to many changes in the molecular properties of proteins
and mRNAs - the majority of the alterations being changes in binding specificities
and functionalities. Many apoptotic factors involved in programmed cell death are
also alternatively spliced. Some important functional consequences of alternative
splicing of known proteins are summarized in Table 1.2.
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1.3.2 Drosophila sex determination is regulated by alterna-
tive splicing
Perhaps the most well-known example of alternative splicing regulation is the sex
determination in Drosophila. The Drosophila sex-lethal (Sxl) protein is the key
RNA-binding protein that determines the sex of a fly. Active Sxl proteins are pro-
duced in female flies primarily because transcription of the Sxl gene utilizes the early
upstream promoter. In the male flies, the downstream promoter is utilized instead,
leading to inactive Sxl products. Active Sxl products, promote the splicing and
production of downstream active RNA-binding proteins such as transformer (tra),
which in turn interacts with Transformer2 protein to produce female-specific dou-
blesex (dsx ) isoforms. In contrast, inactive Sxl products result in the downstream
production of male-specific dsx isoforms. The selection of the early upstream pro-
moter in females is due to four transcription factors present on the X-chromosome,
that bind directly to the upstream promoter and are expressed prior to dosage com-
pensation. The expression of these transcription factors are twice as high in females
compared to males, thereby enabling a stable expression from the early, upstream
promoter [31].
1.3.3 The role of nonsense-mediated decay in alternative
splicing
Nonsense-mediated decay (NMD) is a mechanism by which cells remove deleterious
transcripts. In mammals, NMD occurs when a termination codon resides more than
50-55 nucleotides upstream of an exon-exon junction [32]. The link between NMD
and alternative splicing has been supported by several studies [33, 34], that suggest
that NMD might play an important role in the removal of PTC-containing (pre-
mature termination codon containing) isoforms. However, not all PTC-containing
splice variants are regulated by NMD, in fact only a small proportion of these tran-
scripts are regulated by NMD, since the authors have observed uniformly low levels
of PTC-containing transcripts in normal mammalian tissues which are independent
of NMD [35].
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1.3.4 Tissue-specific alternative splicing
An important function of alternative splicing would be to generate tissue-specific iso-
forms. One observed mechanism that controls the tissue-specific splicing patterns
of variant transcripts is their regulation by tissue-specific splicing factors. Of par-
ticular note, the splicing factor, NOVA-1, is a neuron-specific splicing factor which
is essential for neuronal viability [36]. Other essential splicing factors such as SR
proteins and hnRNPs have been observed to have varying concentrations in differ-
ent tissues [11], which suggest that the selective concentrations of these antagonistic
factors might play a role in altering splicing patterns in a tissue-dependent manner.
1.3.5 Altered splicing in cancer and diseases arising from
mutations or factors affecting enhancer regulatory el-
ements
Mutations in splicing regulatory elements, overexpression of splicing factors, and
overexpression of abberant alternatively spliced transcripts can give rise to diseases
whose fundamental pathogenic mechanism is aberrant expression of splice forms.
Missplicing has been observed in a number of tumour-associated genes. The breast
cancer susceptibility gene, BRCA1, is an example in which mutations in regulatory
elements lead to exon skipping [37], disruption of exonic splicing enhancers [38],
and use of cryptic splice sites [39]. Other splicing defects implicated in cancer may
be due to alterations in the relative concentrations of splicing factors, leading to
different ratios of alternative splice forms between tumours and their corresponding
non-tumourous tissues. It is still unclear whether the change in splicing is a trigger
for tumorigenesis or a symptom resulting from disease progression [40]. However,
recent work by Kim et al. [41] have shown that a number of cancer-specific genes
are involved in mRNA processing, suggesting that aberrant splicing patterns are a
result of alterations in genes involved in the splicing machinery rather than being
the result of disease progression.
A recent review by Solis et al. [42] focuses on human genetic diseases arising
from mutations in splicing enhancer elements. These include spinal muscular at-
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rophy, frontal-temporal dementia with parkinsonism linked to chromosome 17, and
muscular dystrophy (See Fig. 1.4). In essence, mutations within enhancer elements
for these genetic diseases result in exon skipping.
Figure 1.5: Mutations in the dystrophin gene results in exon skipping. Mutations in
the dystrophin gene that causes muscular dystrophy (MD), which is an X-linked recessive disease.
The disease is characterized by the degeneration of skeletal muscles due to the fact that dystrophin
is a structural cytoskeletal protein which maintains membrane stability and communication be-
tween the extracellular matrix and the cytoskeleton. Two types of MD are known: Duchenne and
Becker’s with the former of the two being more severe. In Duchenne MD, a mutation affects the
exonic enhancer element resulting in a frameshift, nonsense-mediated decay, and complete loss of
dystrophin whereas in Becker’s MD, a nonsense mutation creates an exonic silencer element that
does not result in a frameshift and some dystrophin can be produced. Figure extracted from Solis
et al. [42].
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1.4 Computational approaches to study alterna-
tive splicing
To address alternative splicing using computational approaches requires one to un-
derstand the limitations of the computational tools and data sources available. This
section aims to give an introduction to the relevant tools available and to explain
why certain tools and data sources were utilized in the current study.
1.4.1 Tools used to detect alternatively spliced events
Two essential components that are pertinent for alternative splicing analysis are a
robust algorithm for accurate splice-junction inferences and an automated splice-
analysis pipeline to annotate and store the most up-to-date splicing variations when
new genome or transcript data becomes available.
The purpose of splice alignment algorithms is to align transcripts to their re-
spective genomes, which allows us to obtain locations of intron-exon boundaries
necessary to detect alternative splice variation. The challenge for splice alignment
algorithms is that transcripts such as ESTs, cDNAs, and mRNAs are never com-
pletely identical to the genome due to mutations and sequencing errors, thus com-
plicating the detection of splice sites.
To date, several heuristic splice alignment programs such as sim4 [43], spidey
[44], BLAT (BLAST-like alignment tool) [45], GMAP [46], SPA [47], and most
recently PALMA [48] have been developed. Most of the splice alignment programs
are similar in the sense that they start by using a local alignment search tool such
as BLAST or BLAT to quickly find approximate matches between a query mRNA
and target genomic sequence, and then filtering these matches for the best mRNA-
genomic alignment. The programs vary in their approaches to identifying splice
sites, parameters used during processing, speed and memory usage, sensitivity and
specificity, as well as other specific functions such as microexon identification which
has been incorporated in programs such as GMAP and more recently PALMA.
Despite the availability of other alignment programs, SPA (Spliced Alignment
Algorithm) has been developed by our group for various reasons. One reason is that
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SPA is capable of incorporating prior information to infer the best gene structure
for a particular organism or dataset under study. SPA’s scoring function consists
of contributions from two models: i.) sequencing error model - in which we assume
that the resulting sequenced cDNA is different from the original transcript due
to sequencing errors. Thus, the aim is to compute how likely one observes the
cDNA given the likelihoods of misincorporations, insertions, and deletions of bases
of variable lengths that can arise during sequencing, and ii.) gene structure prior
model - in which we compute how likely a given mapping is observed based on
the prior probabilities of intron and exon lengths and the occurrences of canonical
and noncanonical splice-site sequences. Thus, the unique feature of the scoring
function of SPA is that it does not assume the same adhoc scoring parameters for
all species and different sequencing technologies, but rather it adapts itself to the
given situation by initially performing parameter estimations either directly on the
input or on a subset of the dataset (See Fig. 1.6 for a schematic summary of SPA).
These estimated parameters are then used to find the best mapping.
Figure 1.6: A flow-chart of the SPA algorithm. Figure extracted from van Nimwegen et al.
[47].
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Although, other alternative splicing and gene structure databases exist, it is still
crucial to have one’s own automated splicing pipeline - the primary reason being that
one needs to have better control on how the alternative splicing data is generated
as new transcript and genome data becomes available. The studies described here
utilize our in-house pipeline, namely SPAED (SPlice Analyis of EST Data), which
consists of the following steps: i.) Alignment of transcripts to the genome, ii.)
Clustering of transcripts according to their orientation and genomic location, and
iii.) Annotation of splice variation for all transcripts in each cluster. The splicing
pipeline has been developed and utilized previously by Zavolan et al. [49] to esti-
mate the frequencies of different patterns of alternative splicing in mouse full-length
cDNA transcripts and to further examine the functional significance of alternative
transcriptional start/stop sites giving rise to alternative initiation and termination
exons. The current version of SPAED uses SPA to perform the alignments. A public
website is also available at http://www.spaed.unibas.ch, where one can query our
databases or view results of our analyses.
1.4.2 Sequence data sources used in computational studies
of alternative splicing
Sequence data sources that are utilized in computational biology contain genome
and transcript data. Genome assemblies are publicly available from several data
sources such as the National Center of Biotechnology (NCBI) and the University
of California Santa Cruz (UCSC). Genome data can be generated from three dif-
ferent types of sequencing techniques: 1.) clone-by-clone shotgun sequencing, 2.)
whole-genome shotgun sequencing, and 3.) hybrid approach - a combination of the
previous two techniques. The clone-by-clone shotgun sequencing technique involves
the construction of a clone-based physical map and then selection of a minimal path
of clones that covers a particular genomic region. A physical map is an ordered
set of DNA fragments, which may be linked to several genetic markers in order to
allow one to identify more clearly the gene’s location. Then, the individual clones
are subcloned into smaller insert libraries whereby thousands of sequence reads for
each random subclone are derived. In whole-genome shotgun sequencing, instead
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of using a physical map, clone libraries are prepared directly from the genome and
millions of sequence reads are generated from these clone libraries. These are then
assembled computationally into the genomic sequence.
The hybrid sequencing approach consist of generating reads from clone-by-clone
and whole-genome shotgun sequencing. The advantage of this approach is that
reads generated from the whole genome approach rapidly provide the entire genomic
landscape whereas the clone-by-clone approach provides enhanced sequence coverage
and thus can correct for any sequence misassemblies [50]
It is difficult to say which genome assembly is the better one since the methods
by which they were generated are so different. However, Rouchka et al. [51] have
previously compared the UCSC Goldenpath assembly against NCBI genome assem-
bly by looking at 50 markers within a small region of genome and have observed
that the NCBI assembly may be more accurate in determining the order of contigs
whereas UCSC Goldenpath is more accurate in determining orientation of contigs.
Nonetheless, this was a small scale study and the question of which genome assembly
is more accurate remains to be investigated further.
The transcript data utilized in computational biology can be grouped according
to their size such as full-length complementary DNAs (cDNAs), which are usually
thousands of base pairs long and short sequence reads (200-800bp) such as expressed
sequence tags (ESTs), which are used quite commonly. ESTs are generated from
reverse-transcribed mRNAs and are commonly utilized to locate the promoters,
poly-A tails and 3’ UTRs, and to profile tissue expression. Since ESTs are gener-
ated from random single-pass sequencing, they can be highly error-prone and need
to be subjected to EST pre-processing. Despite these errors, ESTs still remain a
rich resource for gene analyses in organisms whose large genomes are too expensive
to sequence [52]. Full-length cDNAs are also generated from reverse-transcribed
mRNAs and they can be used to identify complete open reading frames and un-
translated regions, which allow for research into mRNA stability and translational
efficiency. One can obtain mouse and human cDNAs from the Fantom3 group [53]
and the H-Invitational project [54]. The cDNA datasets are not always represen-
tative of transcript abundance in the cell, as there are various sources of errors
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incurred during cDNA library generation, albeit there have been methods to cir-
cumvent many of these errors. Some of these errors include intron contamination
as a result of inefficient RNA fractionation between cytoplasmic and nuclear mRNA
species, RNA transcripts lacking or having shortened poly(A) tails which are selected
against, competition between mRNA species of different sizes during clone transfor-
mation, selection against transcripts with strong RNA secondary structures. Certain
cDNA libraries such as the bacteriophage cDNA libraries contain clones with differ-
ent growth rates which can lead to the loss of clone representation. In any event,
full-length cDNAs provide a better quality dataset than ESTs due to their wider
coverage of the pre-mRNA, but it is still important to keep in mind the putative
sources of error during data interpretation [55].
1.4.3 Genomic approaches to study alternative splicing
The genomic approach involves the use of genome and transcript data to examine al-
ternative splicing. Several studies to date have utilized these data sources to uncover
more information with regards to alternative splicing and they will be discussed in
the following subsections.
Estimates of the frequency of alternative splicing
The frequency of alternative splicing in individual organisms such as human and
mouse has been shown to be high and percentage estimations are as high as 74%
when using microarrays [56]. Other studies focus on the estimation of the frequency
of conserved alternative splicing between mouse and human. For example, a study
from Sugnet et al. [57] estimated that 10% (1964/19156) of mouse and human
alternative splicing events are conserved. Of these conserved events, exon skipping
is most frequent (38.4%), followed by alternative acceptor (18.4%) and donor (7.9%)
variations, with intron-retention and other splicing patterns coming last. Thanaraj
et al. [58] have also shown that the frequency of human alternative splice donor and
acceptor splice-site usage is quite high in mouse (61%).
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Sequence features of alternatively spliced exons
Based on genomic studies, several features of alternatively spliced exons have been
uncovered: 1.) higher intronic sequence conservation flanking alternatively spliced
exons compared to constitutively spliced exons [57, 59, 60], 2.) shorter exon lengths
relative to constitutively spliced exons [60], 3.) higher frequency of reading frame
preservation amongst those alternatively spliced exons that are included in a mi-
nority of transcripts [Resch et al. 2004], 4.) weaker donor and acceptor splice-site
strengths relative to constitutive exons [61, 60], 5.) higher density of regulatory
sequences (purine-rich motifs that resemble enhancer elements) relative to constitu-
tive exons [61], and 6.) higher frequency of premature termination codons relative
to their constitutive transcripts [33]. These features have mostly been studied in
human and mouse datasets.
Microarray approaches to detection of tissue-specific alternative splicing
events
We define tissue-specific alternative splicing events as splicing events that occur
specifically in a restricted number of tissues. The typical approach to detecting
alternatively spliced events using microarrays is to design probes that span the splice
junctions confirming alternative splicing events. The detection of exon-skipping
events appears to be more common as the probes are more easier to design. A
sketch of one approach to finding tissue-specific cassette exons using a 2-color cDNA
microarray approach is illustrated in Fig. 1.7.
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Figure 1.7: Microarray approach towards detection of alternatively spliced tissue-
specific events. In this example, cassette exons are being detected in two different tissues, X and
Y. The cDNAs from these tissues are labeled with green and red fluorescent dyes. Constitutive
exons are labeled C1 and C2, whereas the cassette exon is annotated as exon A. In panel A, probes
covering the splice junctions and every exon are shown. If exon A was missing in transcripts
derived from tissue X, then we would not get signals from the probes: C1-A, A, A-C2. In panel
B, a fictional hybridization pattern is obtained if we used Cy3-labeled tissue X cDNA (green) and
Cy5-labeled tissue Y cDNA (red). The different colored spots indicate detection of signals from
probes hybridized to the labeled cDNA from tissues X and Y. Data needs to be processed using
an appropriate algorithm to predict the alternative splicing levels of alternative exons. Figure
extracted from Blencowe,B. [62].
May 30, 2008
1.4. Computational approaches to study alternative splicing 22
Microarray approaches towards detecting tissue-specific alternative splicing events
have been used by Johnson et al. [56] to identify tissue-specific alternative splicing
events in human as well as by Sugnet et al. who identified cassette exons that are dif-
ferentially expressed between brain/muscle and non-brain/non-muscle tissues [63].
In addition, Clark et al. [64] have used human exon arrays to profile with probes
covering only the individual exons in the human genome in 16 adult normal tissues.
By comparing gene-level-normalized and exon-specific expression values, they were
able to detect tissue-specific alternatively spliced exons.
It seems that many alternative splice forms are tissue specific. The frequency of
alternative splicing events appears to be highest in brain, testis, and the immune
system [65, 66], thus suggesting a more complicated and diverse regulation within
these tissues.
1.4.4 Structural insights from proteomic approaches
The proteomic approach to addressing questions about alternative splicing essen-
tially boils down to how the splicing event affects the resulting properties of pro-
teins. Properties such as protein folding, protein stability, and disruption of protein
domains can be affected by alternative splicing events. We need to consider several
key issues when performing such analyses: i.) finding enough protein 3D structures
to perform the analysis, ii.) correctly mapping the alternative splicing event to the
correct region within the 3D structure, and iii.) accurate assessment of the effect of
the alternatively spliced event on the protein function. Although the number of pro-
tein 3D structures in Protein Data Bank (PDB) is still limiting when compared to
the number of transcript sequences in public databases, several studies have begun
to investigate the functionality of alternative splicing using 3D protein structures
and we will discuss their results shortly.
Earlier studies that evaluated the effect of alternative splicing on protein 3D
structures reported mixed results: one study [67] observed that small splice varia-
tions (<50 nucleotides) are likely to influence the tertiary structure of the proteins.
Another study found that the majority of human alternatively spliced junctions
occur in protein domain boundaries with an insignificant tendency to avoid being
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located inside protein domains [68]. Several other studies [69, 54, 70, 71] with larger
datasets found that alternative splicing events affect protein domains that are in-
volved in signal subcellular localization and protein-interaction binding sites. Finally
some studies suggested that alternatively spliced regions may be located to avoid
structural implications: i.) Romero et al. have reported that alternatively spliced
events tend to occur in protein regions that are intrinsically disordered [72], ii.)
Alternatively spliced junctions tend to avoid annotated protein domains and have
strong preferences for loop and exposed regions in protein secondary and tertiary
structures respectively [73, 74].
Recently, Tress et al. [69] raised an interesting, yet debatable viewpoint that
although many alternative splicing events, that may be deleterious, can greatly
affect the structure of a protein, there is not much evidence in literature to prove that
alternative splicing gives rise to much protein functional diversity. The author has
suggested that alternative splicing may have another role other than to expand the
protein functional potential and that perhaps the organism is capable of tolerating a
high number of abberant protein isoforms. The mechanisms of such tolerance have
not been elucidated. Given this observation, the picture is likely to be clearer as
more protein structures become available.
FireDB and Firestar - useful tools for assessing functionally important
protein residues
FireDB [75] is a database containing functionally important residues from proteins
of known structure. The database consists of all PDB sequences in which only those
sequences with >97% identity are grouped into one cluster and consensus sequences
are generated for each cluster through multiple protein sequence alignments. In
addition, each consensus sequence also contains residue reliability information, which
is a measure on how conserved and reliably aligned a particular amino acid is within
a multiple sequence alignment. The reliability score calculations are done using
SQUARE [76], which is a web-based version of the method developed by Tress
et al. [77]. Their method assesses the quality of alignments between unknown
query and template sequences of known structure and the aligned positions are
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scored using profiles generated from template sequences. The alignment scores are
then smoothed using a triangular five-residue window and from these smoothed
scores, reliably aligned regions are then determined. The consensus sequence for each
cluster is annotated with functional binding-site information obtained from Catalytic
Site Atlas (CSA), the literature, databases containing protein-ligand interaction
annotations, and conserved binding sites from other proteins.
To exploit the potential of FireDB, the same authors have also developed an-
other tool namely Firestar, which predicts ligand-binding residues in protein query
sequences. Firestar [78] takes in a protein query sequence as input and performs a
pairwise PSI-BLAST against the PDB, then a final search is made to the FireDB
consensus database. As mentioned before, binding-site annotations are associated
with each consensus sequence and residue reliability scores are also calculated be-
tween the query and consensus sequence using SQUARE. However, these reliability
scores are calculated from PSI-BLAST profiles, which are pre-generated for each con-
sensus sequence (profiles are generated from the nonredundant database (nrdb90)
from the European Bioinformatics Institute). Thus, depending on how good the
reliability scores are, we can transfer the functional binding-site annotations from
the consensus sequences in FireDB to our query sequence.
In chapter 2, we have utilized FireDB and Firestar, to assess the functional
impact of single amino acid insertions/deletions arising from the usage of short
tandem acceptor splice sites.
1.5 Evolutionary insights into alternative splicing
from computational analyses
This section addresses how mammalian splice sites and other splicing regulatory
features have evolved and provides some insights into the mechanism of alternative
splicing from an evolutionary standpoint. Most of the points addressed here have
already been covered by the review written by Xing and Lee [79], but here we offer
a brief summary.
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1.5.1 Orthologous exons and their inclusion levels
Conserved alternatively spliced cassette exons between mouse and human represent
approximately 10-20% of all cassette exons, thus suggesting that there is much
species-specific alternative splicing to be explored [80, 81, 82]. Modrek and Lee
[80] observed a linear correlation between the conservation of mouse and human
orthologous exons and their inclusion levels: highly conserved orthologous exons
have high inclusion levels and vice versa.
1.5.2 Strength of splice-site signals
Recently, Schwarz et al. [83] have performed comparative analyses (from fungi to
mammalians) to study the evolution of splicing signals. The authors have found that
the strength of the polypyrimidine tract has slowly increased from fungi to meta-
zoans. In addition, the 5’ss and branch sites were most degenerate in the majority of
the organisms examined with the exception of fungi. Lastly, their analyses revealed
that the strength of the polypyrimdine tract is correlated with changes in residues in
their corresponding splicing factors, indicating that the splicing regulatory signals
are evolving simultaneously with their corresponding splicing factors.
1.5.3 Is organismal complexity correlated with increasing
alternative splicing?
A few studies have attempted to examine rates of alternative splicing between ver-
tebrates and invertebrates and have yielded mixed results. According to the work
performed by Brett et.al [84], alternative splicing occurs at comparable frequencies
amongst vertebrates and invertebrates whereas other studies have reported higher
frequencies in vertebrates compared to invertebrates [79, 85].
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1.5.4 Correlations between alternative splicing and tandem
exon duplications
Letunic et al. [86] have estimated that about 10% of all genes in human, worm and
fly contain conserved duplicated exons. They took a subset of those annotated exons
with duplications and estimated that between 59−62% of these exons are subjected
to mutually exclusive splicing, a type of alternative splicing, in which alternative
exons are not observed in the same transcript. Interestingly, the authors have iden-
tified a duplicated exon within the human glycine receptor alpha-2 gene, which was
also known to be a candidate for alternative splicing. With cDNA evidence, the
authors confirmed that the duplicated exons were mutually exclusively spliced into
resulting gene products. By mapping the duplicated exon to their relevant protein
structure, the authors found that the substitution between the two duplicated exons
might affect the function of the receptor.
1.5.5 Correlations between alternative splicing and Alu trans-
posable elements
The majority of Alu transposable elements are found in approximately 4% of human
protein-coding regions. The Alu elements contain potential splice donor and accep-
tor splice sites and new exons are created upon their insertion into the intron. Ac-
cording to Sorek and colleagues, most Alu-containing exons are alternatively spliced
[87]. One possible exon-creation mechanism proposed by Lev-Maor et al. [88], is
that it only takes one mutation for intronic Alu elements to convert the intronic
sequence to an exon. How transposable elements may play a role in the alternative
splicing of protein-coding genes is not completely clear, but a few examples such
as the Bim-beta3 [89], suggest that introduction of an Alu element into the coding
region of genes can result in the creation of alternative translational start sites or
the generation of new Alu-encoded exons.
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1.5.6 Major and minor exons
Modrek and Lee [80] classified alternative exons into ’major’ and ’minor’ form ex-
ons, whereby the major form is defined as the alternative transcript confirmed by
more transcript copies than the minor form. Major form exons are more conserved
between mouse and human than minor form exons and they are also more similar
to constitutive exons. Minor form exons, being less conserved, appear to have been
created recently [90, 91]. In addition, the flanking introns of minor-form exons are
more conserved between mouse and human than constitutive exons suggesting their
functional importance [92]. Xing and Lee [79] suggested that the purpose of intro-
ducing minor-form exons through alternative splicing is to allow the newly created
alternative exon to experience little negative selection pressure and thus, permit
evolutionary changes to occur in genes.
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Investigation of short tandem
acceptor splice sites
2.1 Introduction/Rationale
In the literature review (Chapter 1), we discussed several functional, biological con-
sequences of alternative splicing. However, alternative splicing may be due simply
to the noise in the splicing process. The idea of spurious splice variation as a re-
sult of stochastic choice of splice sites was first suggested by Kan et al. [93] and
Zavolan et al. [49]. Kan and others have observed that many alternatively spliced
events detected in ESTs could not be confirmed in other sequence data or through
conservation and that theoretically these spurious events might exist in the cell, but
occur at lower frequencies. In support of this view, Zavolan and others have also
observed frequent small variations (less than 10 nucleotides) at donor and acceptor
splice sites, thus suggesting that the spliceosome may slip near acceptor splice-site
boundaries.
In line with the interest in small exon-length variations occurring at splice-site
boundaries, another observation by Hiller et al. [94] reported the frequent occur-
rence (up to 30% in human genes) of short tandem, acceptor splice sites, termed
’NAGNAGs’. These acceptor splice sites are adjacent to each other and selection of
one of the acceptor splice sites will lead to either the inclusion of one amino acid (if
the first acceptor splice site is chosen) or deletion of a single amino acid (if the sec-
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ond site is selected). The same authors have proposed that these NAGNAGs have
the potential to increase the protein functional diversity through the inclusion and
exclusion of one amino acid. Although there are only a few experimentally-validated
functional NAGNAG acceptor splice sites in literature, the presumably first, func-
tional NAGNAG case did make its appearance 14 years ago, when Condorelli and
others [95] have found distinct biological differences of NAGNAG isoforms of the
human insulin-like growth factor I receptor. The interest in NAGNAG acceptor
sites increased slightly after Hiller et al.’s study highlighted its prevalence in the
human genome [94]. Thereafter, other research efforts have begun to focus on single
nucleotide polymorphisms (SNPs) in NAGNAGs [96] and on finding tissue-specific
differences between the included and excluded NAG forms [97]. NAGNAG events
have also been detected in plants. Recently, Iida et al. [98] have detected between
300-400 NAGNAG events in Arabidopsis and rice. The precise mechanism by which
these tandem alternative acceptor splice sites are chosen by the splicing machinery
is not well understood. However, recent mutation experiments by Tsai and others
[99] suggest that the region from the branchpoint sequence to the NAGNAG splice
sites is important for splice-site selection.
We have explored, in more depth, the frequencies of small exon-length varia-
tions, the evolutionary and functional characterization of NAGNAG tandem accep-
tor splice-site motifs, and the spliceosomal binding affinities of NAGNAG tandem
acceptor splice sites computed from our weight matrix (WM) models. The work has
revealed that the binding of the spliceosome at NAGNAG tandem acceptor splice
sites can be competitive, which would also allow possible stochastic binding at these
sites confirming earlier studies on the possibility of noise in the splicing process. In
support of this view, we did not have enough evidence from our evolutionary and
functional characterization of NAGNAG motifs at tandem acceptor splice sites to
suggest that the majority of these single amino acid insertions and deletions can
increase the functional protein repertoire.
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2.2 Methods and Results
The work performed in sections 2.2.1 - 2.2.9 has already been published in the
PLoS Genetics article entitled ’A simple physical model predicts small exon-length
variations’ and a copy is included in Chapter 5. Please refer to the Materials and
Methods section in the paper for a detail description of sections 2.2.1 - 2.2.9. Other
methods not present in the paper will be described in the relevant sections.
2.2.1 Abundance of small exon-length variations at acceptor
splice sites
We started our analyses in mouse by first obtaining datasets that are annotated
with alternative acceptor and donor splice-site variation. In brief, we did this by
mapping mouse full-length cDNA transcripts to their genome using SPA (See lit-
erature review) and using our in-house splicing pipeline (SPAED) to annotate the
splice variation. From our initial dataset of acceptor and donor sites, we have sub-
divided them into three categories: 1.) those sequences that have coding sequence
annotation (CDS), but have their site-of-variation fall within the CDS, 2.) those
sequences that have coding sequence annotation, but have their site-of-variation fall
outside of the CDS, which we term as the ’UTR’ group, and 3.) those sequences that
do not have any coding sequence annotations and come from transcription units in
which none of the transcripts had a CDS annotation, which we call the ’noncoding
exons’. We totalled the number of unique exon-length variations at donor and ac-
ceptor splice sites and have observed that the total number of acceptor variations
(2295) was greater than the donor variations (1689). Please see Fig. 2.1 on the
frequency of exon-length variations for each exon-type category.
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Figure 2.1: Frequency of length variations of different sizes at donor(left) and ac-
ceptor(right) splice sites. The figures show the observed counts of splice events occurring at
different distances from the most commonly used splice site in transcripts originating from the
same gene, which we termed as reference boundary. The red, black, and blue distributions corre-
spond to alternative exons belonging to the CDS-, UTR-, and noncoding exons respectively. The
figures highlight that variations, which are multiples of three are common in CDS exons at both
donor and acceptor splice sites, whereas this is not the case for splice sites of noncoding exons.
Figure taken from Chern et al. [100].
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In addition, we have also tallied those exon-length variations, in which the exon-
length difference was less than 10 nucleotides, for donor and acceptor splice sites, and
have observed once again that small acceptor variations (955) were larger than their
donor variations (348). Interestingly, small acceptor splice-site variations constitute
42% of all acceptor splice-site variations versus only 21% was observed for small
donor splice-site variations.
We have decided to examine which small exon-length variation contributes most
in small acceptor and donor splice-site variations, and have found that for small
acceptor splice-site variations, those that cause an exon length difference of 3 nu-
cleotides, constitute 58% (554/955) of all small acceptor splice-site variations. In
contrast, among small donor splice-site variations, those of one and four nucleotides
contributed the most (18.4% and 20.1% respectively) to all small donor variations.
2.2.2 Abundance of in-frame exon-length variations at ac-
ceptor splice-site boundaries
Exon-length variations that are not a multiple of three most likely cause frame-shifts
that lead to transcript degradation by NMD. Thus, we computed the frequencies
of all multiple of three (in-frame) variations in both donor and acceptor splice sites
and in all exon-types (CDS, UTR, and noncoding exons). In addition, we compared
the frequencies to those expected by chance, which is 1/3. We have observed that
the frequency of in-frame variations for acceptor splice-site boundaries in all exon
types exceeded 1/3, whereas for donor splice-site boundaries, only the frequency in
CDS exons was greater than expected by chance (See Fig.2.2).
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Figure 2.2: Proportion of in-frame alternative acceptor and donor splice-site events.
The histogram shows alternative acceptor (3’) and donor (5’) splice-site events of CDS, UTR, and
noncoding (NC) exons, in which the splicing event leads to in-frame shifts with respect to their
reference boundaries. The estimated fraction is in the middle of the gray bar, with the width of
the gray bar indicating two standard errors. The horizontal dashed line represents the fraction
1/3, that would be expected by chance. Figure taken from Chern et al. [100].
May 30, 2008
2.2. Methods and Results 34
We will explain shortly that the differences in the proportion of in-frame vari-
ations between donor and acceptor splice sites is due to the differences in their
sequence composition within the first few bases of donor and acceptor splice sites of
small exon-length variations that causes nucleotide shifts of 1-4 bases.
2.2.3 Overrepresentation of in-frame exon-length variations
that causes nucleotide shifts of more than 4 bases in
coding sequence exons
At a closer examination, we observed that for exon-length variations of more than 4
nucleotides, the patterns of variation are similar between donor and acceptor sites:
only variations in CDS exons are enriched in multiples of 3 (See Fig. 2.3). This
suggests that a common mechanism that is sensitive to the reading frame such as
NMD is responsible for the observed enrichment.
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Figure 2.3: Proportion of in-frame alternative acceptor and donor splice-site events
that causes exon-length differences greater than 4 nucleotides. The histogram shows
alternative acceptor (3’) and donor (5’) splice site events of CDS, UTR, and noncoding (NC) exons,
in which the splicing event leads to in-frame shifts with respect to their reference boundaries. The
estimated fraction is in the middle of the gray bar, with the width of the gray bar indicating two
standard errors. The horizontal dashed line represents the fraction (1/3), that would be expected
by chance. The last two bars on the right represent the data from all CDS and non-CDS exons
pooled. Figure taken from Chern et al. [100].
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2.2.4 The proportion of in-frame putative donor and accep-
tor splice sites is close to the proportion expected by
chance
We tried to explain the excess of in-frame variations at CDS regions in donor and ac-
ceptor groups in terms of the sequence bias at different relative positions with respect
to the reference splice boundary. For this, we extracted the intronic sequences of 100
nucleotides flanking all alternative acceptor and donor splice sites and counted the
number of times an intronic AG or GT occurs upstream or downstream respectively
of their corresponding reference splice-site boundary. The occurrences of intronic,
upstream AGs or intronic, downstream GTs within the four nucleotides of the ref-
erence boundary were not counted. We have found that the fraction of in-frame
occurrence of the putative splice-site dinucleotides is close to 1/3 for all exon types,
thus suggesting that there is no bias in the sequence composition flanking CDS ex-
ons of donor and acceptor groups (See Fig. 2.4) and we therefore set to investigate
whether NMD might be responsible for the excess of in-frame variations at CDS
exons.
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Figure 2.4: Proportion of putative donor and acceptor splice sites that are situated
in-frame relative to the splice sites in CDS, UTR, and noncoding regions. The his-
togram shows the counts of AG (3’,acceptor splice site) and GT (5’,donor splice site) dinucleotides
appearing within 100 intronic bases upstream and downstream respectively from their splice sites.
AG and GT occurrences within the first 4 nucleotides were excluded from the counts. The es-
timated fraction is in the middle of the gray bar, with the width of the gray bar indicating two
standard errors. The dashed line indicates the fraction (1/3) that would be expected by chance.
Figure taken from Chern et al. [100].
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2.2.5 Estimation of the fraction of frameshifting exon-length
variations that survive NMD
It is well known that transcripts containing premature stop codons are subjected to
NMD [32]. We reasoned that it is likely that the observed enrichment of in-frame
variations in CDS exons is due to NMD removing some of the out-of-frame variants,
and we set to estimate the fraction of out-of-frame variations that survive NMD.
If we assume our fraction of in-frame variations at CDS exons before NMD is 1/3,
which we term as pi, and that a proportion of out-of-frame variants survive NMD,
then the observed proportion of in-frame variants that we observe after NMD is
given by:
po =
pi
pi + f(1− pi) (2.1)
Solving this equation for f with pi = 1/3 and po = 0.48, we obtain f=0.53. This
suggest that only 47% of out-of-frame variations are removed by NMD. We then
used this fraction (f=0.53) to estimate the proportion of exon-length variations of
1-4 nucleotides before NMD.
So far we have shown that in-frame variations were more frequent at acceptor
splice sites than at donor splice sites (See Fig. 2.2), yet when we focus our attention
to only those exon-length variations of more than 4 nucleotides, we found that
the proportion of in-frame variations for donor and acceptor splice sites were quite
similar (See Fig. 2.3). The scenario is different for very small exon-length variations
of one to four nucleotides. As shown in Fig. 2.5 (A and C), we observe more in-
frame variations of precisely three nucleotides at acceptor splice sites than at donor
splice sites, where frameshifting variations of 1 and 4 abound. In previous sections
of this chapter, we argued that the excess of in-frame variations at CDS exons is
due to NMD and now we set to demonstrate that very small exon-length variations
(1-4nt) can be explained by a combination of stochastic binding of the spliceosome
at competing splice sites and NMD.
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Figure 2.5: Distributions of very small exon-length variations occurring at acceptor
and donor splice sites that cause exon-length differences of one to four nucleotides.
Histograms on the left column indicate observed acceptor (top) and donor (bottom) distributions
of small exon-length variations before NMD. The fractions of all exon types (CDS, UTR, and
noncoding) were pooled since their frequencies were similar. The frequency of variations of length
3 was rescaled to take into account the effects of NMD. On the right column, predicted acceptor
and donor distributions are shown from our weight matrices, which we will explain shortly. The
estimated relative frequency is in the middle of the gray bar, with the width of the gray bar
corresponding to two standard errors. Figure taken from Chern et al. [100].
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2.2.6 A high frequency of NAGNAG motifs was found in
alternative acceptor splice sites that causes an exon
length difference of 3 nucleotides
Earlier, we have mentioned that small acceptor variations that cause an exon length
difference of 3 nucleotides, contribute towards 58% of all small acceptor variations
(<10 nucleotides). Now, we focus our attention to these three-nucleotide acceptor
variations and we divide this dataset into 3 categories: those transcripts that contain
our site-of-variation in the coding sequence and have coding sequence annotation
(CDS), those transcripts that contain our site-of-variation in the untranslated re-
gion, but also have coding sequence annotation (UTR), and those transcripts that
do not have coding sequence annotations (NC) and come from transcription units
in which none of the transcripts have coding sequence annotations. Within each
of these groups, we have computed the frequency of NAGNAG motif occurrence,
computed the most frequent NAGNAG motif(s) within that group, and calculated
the NAGNAG motif percentage conservation to its human ortholog (See Table 2.1
below). We have defined sequence conservation as perfect conservation of the nu-
cleotides within the NAGNAG motif. We find that 95% of all three-nucleotide
acceptor variations in CDS group contain NAGNAG motifs, followed by over 50%
of NAGNAG-containing splice boundaries in other groups. The most frequent motif
observed in each group was CAGCAG and the percentage conservation was highest
in the CDS group.
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It is difficult to imagine how the spliceosome can choose in a regulated manner
a splice site among variants that are 1-4 nucleotides apart with such high precision,
we reasoned that a likely factor determining splice-site selection is the strength of
the alternative splice sites. If one of the alternative acceptor splice sites is stronger
than the other, then one expects that the stronger acceptor would be selected by
the spliceosome. To test this, we have measured the relative strength of alternative
splice sites (NAGNAG tandem acceptor splice sites) as follows: We extracted the
intronic and exonic sequences spanning the splice boundaries of variant and invariant
exons. We constructed a weight matrix (WM) based on invariant splice sites and
used it to estimate the strength of NAGNAG-containing alternative acceptor and
invariant acceptor splice sites.
The reason for using a WM constructed from invariant splice sites to score tan-
dem acceptor sites is that for invariant splice-site sequences, the spliceosome will
efficiently and reliably recognize the stronger splice site (See Fig. 2.6). The like-
lihood of a candidate splice site is given by the product of the base probabilities
at each position in the splice site as given by the WM. We obtained log-likelihood
scores for all variant and invariant acceptor splice sites containing NAGNAG motifs.
We have also constructed a donor site WM and have used this WM to predict the
relative frequencies of small exon-length variations (See section 2.2.9).
Figure 2.6: Sequence composition of invariant donor and acceptor splice sites. The
weblogos illustrate the weight matrices of donor (left) and acceptor (right) splice sites. The weight
matrices are constructed from six intronic and six exonic nucleotides spanning the splice boundary.
The relative size of the letters reflect the relative frequency of each base at each position. However,
the total height of each column represents the information content in that column, expressed in
bits. Figure taken from Chern et al. [100].
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We then sought to determine whether the relative likelihoods of the two putative
sites in NAGNAG acceptors can explain the relative frequency with which the two
sites are used in splicing reactions. The results are shown in Fig. 2.7. In blue, we
show the distribution of log-likelihood differences of variant NAGNAG sites (both
sites have been used in the splicing reaction), in red we show the log-likelihood
differences of invariant NAGNAG sites (in which the first site is used), and the
green distribution shows that log-likelihood differences of invariant NAGNAG sites
(in which the second NAG site is used). The figure indicates that, as expected,
when the likelihoods of the competing acceptor sites are similar, they are both
used in splicing reactions, whereas when one or the other of the competing tandem
acceptor site has a much higher likelihood than the other, then only the site with the
higher likelihood is used in the splicing reaction. Thus, based on their log-likelihood
differences, we were able to distinguish between variant and invariant NAGNAG
splice sites. In addition, the fact that the likelihoods of variant competing acceptor
sites are similar suggests that the spliceosome may choose one of the NAG sites in
a stochastic manner.
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Figure 2.7: Dependency of the frequency of alternative splicing at NAGNAG sites
on the relative likelihood of the two putative acceptor sites. The relative likelihood is
calculated by taking the difference between the log likelihood of the first and second NAG using
our WM constructed from invariant splice sites. The red, green, and blue distributions correspond
to tandem acceptor splice sites containing NAGNAG motifs in which the spliceosome splices only
at the first NAG (red), only at the second NAG (green), and splices at both NAGs (blue). Figure
taken from Chern et al. [100].
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2.2.7 NAGNAG motifs are also frequent and even more
conserved at invariant acceptor sites
In order to infer the functional importance of NAGNAG motifs, we have also checked
whether the high NAGNAG motif frequency is only observed at alternative acceptor
splice sites. To address this question, we have obtained 130689 invariant, constitu-
tive exons that do not show any alternative splicing at their acceptor splice sites.
We have searched for NAGNAG motifs in two distinct regions surrounding the con-
stitutive splice boundary for each exon - (i) six intronic nucleotides upstream of the
splice boundary, and (ii) six nucleotides spanning the splice boundary (3 intronic
nucleotides upstream and 3 exonic nucleotides downstream from the splice bound-
ary) were extracted. As a control, we have also extracted all possible hexameric
motifs spanning the invariant constitutive splice boundary.
We find that the majority of the NAGNAG motifs occurs across the splice bound-
ary in invariant exons (6052/130689=4.6%), although these motifs were also found
in the intronic portion upstream of the splice boundary (663/130689=0.37%). The
most common NAGNAG motifs observed for invariant exons were CAGGAG (45.6%
occurring across the splice boundary) and GAGCAG (34.8% six intronic nucleotides
occurring upstream of the splice boundary).
We then compared the conservation levels of the NAGNAG motif observed in
all groups of invariant exons and have found that NAGNAG motifs occurring across
the splice boundaries of invariant exons were more conserved (2897/6052=47.9%)
than those motifs extracted only from the intronic portion (183/663=27.6%). In-
terestingly, if we compare the proportions of those NAGNAGs occurring in variant
CDS exons against the invariant NAGNAGs occurring across the splice boundary,
the conservation is higher for NAGNAGs in invariant exons (p-value =0.03) than
the NAGNAGs occurring in variant CDS exons. In addition, if we compare the
conservation levels of any hexameric motif across the splice boundary of invariant
exons (63001/126817=49.7%) to the NAGNAG conservation levels of variant CDS
exons, we find that the conservation levels of any hexameric motif across invariant
splice boundaries is significantly higher than the NAGNAG conservation levels for
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variant exons (p-value=0.002). These results suggest that NAGNAG motifs at vari-
ant splice boundaries are not under stronger selection pressure than any other motif
occurring at the splice boundary.
2.2.8 Frequencies of NAGNAG motifs at the splice bound-
aries of noncoding exons are significantly higher than
at the splice boundaries of coding exons
To check whether the presence of NAGNAG motifs is preferred in CDS exons, we
have computed the frequencies of NAGNAG motifs occurring at all coding exons
and noncoding exons. For noncoding exons, we pooled the frequencies of NAGNAG
motifs occurring in both UTR and noncoding groups. We have found the NAGNAG
frequency in noncoding exons to be 6.2% (958/15379), which is significantly higher
than the 5.4% (6239/115086) observed in coding exons (p-value=4.1e−05). These
results indicate that NAGNAG motifs are not more frequent in regions in which
alternative splicing would result in higher proteome diversity.
2.2.9 Prediction of relative frequencies of observed small
exon length variations of 1−4 nucleotides from weight
matrices are accurate
In addition to using our WMs to predict the binding affinities of the spliceosome
on alternative acceptor splice sites, we used our donor and acceptor WMs to esti-
mate the relative frequencies of small (1-4nt) exon-length variations. To do this, we
summed over all splice boundaries the probability that a site is located at 1,2,3,4
nucleotides from the reference site that is used in the splicing reaction (according
to its likelihood given by the WM). In order to compare our predicted relative fre-
quencies to observed frequencies of splicing at small exon-length variations, we have
computed the observed frequencies of small exon-length variations ”before NMD”
because we only want to see the effects of splicing and not the effects of splicing and
NMD. Fig. 2.5 (B and D) shows that the predicted acceptor and donor distribu-
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tions are quite similar to those distributions observed before NMD (Fig. 2.5 A and
C), except for the donor distributions in which shifts of 1 and 4 nucleotides were
slightly different between the observed and predicted distributions. Thus our results
show that our predicted relative frequencies are quite accurate when compared to
the observed frequencies.
2.2.10 Extending the polypyrimidine tract does not change
the spliceosomal binding affinity distributions of vari-
ant and invariant acceptor splice sites
Earlier, we had constructed weight matrices of length 12 nucleotides, consisting
of 6 upstream intronic nucleotides and 6 downstream exonic nucleotides from the
splice boundary, which were used to score variant and invariant acceptor splice sites
containing NAGNAG motifs. Our next objective is to check whether increasing the
length of the polypyrimidine tract would affect distributions shown previously in
Fig. 2.7.
We have also mentioned earlier in our literature review that the strength of
the splice site, which includes the strength of the polypyrimidine tract, also affects
splice-site selection. That said, we have constructed weight matrices of length 30,
consisting of 24 upstream intronic nucleotides and 6 downstream exonic nucleotides,
for both mouse and human. For the human data, we used the hg17 University of
California Santa Cruz genome assembly. Using the same procedure to calculate
the likelihood scores for variant and invariant NAGNAG acceptor splice sites, we
show the mouse and human distributions in Figures 2.8 and 2.9 respectively. The
results are qualitatively similar to those obtained with WM of length 12: alternative
splicing occurs at NAGNAG acceptors in which the competing sites have comparable
likelihoods, otherwise the splicing occurs at the site with the highest likelihood.
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Figure 2.8: Mouse log-likelihood distributions using our extended polypyrimidine
tract WM model. The figure shows the mouse difference log-likelihood distributions calculated
using our extended polypyrimidine tract WMmodel. The red, green, and blue distributions refer to
the fraction of all NAGNAG boundaries splicing at the first NAG acceptor, second NAG acceptor,
and at both NAG acceptors respectively.
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Figure 2.9: Human log-likelihood distributions using our extended polypyrimidine
tract WM model. The figure shows the human difference log-likelihood distributions calculated
using our extended polypyrimidine tract WMmodel. The red, green, and blue distributions refer to
the fraction of all NAGNAG boundaries splicing at the first NAG acceptor, second NAG acceptor,
and at both NAG acceptors respectively.
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2.2.11 Similar splicing at NAGNAG acceptors in fly and
human
We have checked whether the splicing at NAGNAG acceptors in mouse is similar
to other species. We have calculated the likelihood scores for the fly and human
using the same procedure as we did for mouse, and aside from the differences in
the frequencies of distributions and extent of overlaps between the distributions, we
observed similar behaviour in both fly and human when compared to mouse: splicing
occurs at the acceptor site with the highest likelihood, and when the tandem acceptor
sites have comparable likelihoods, one observes alternative splicing (Figs. 2.10 and
2.11 for fly and human respectively).
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Figure 2.10: NAGNAG acceptor splicing in the fly. The figure shows the fly difference log-
likelihood distributions calculated using the fly WM model. The red, green, and blue distributions
refer to the fraction of all NAGNAG boundaries splicing at the first NAG acceptor, second NAG
acceptor, and at both NAG acceptors respectively.
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Figure 2.11: NAGNAG acceptor splicing in human. The figure shows the human difference
log-likelihood distributions calculated using our human WM model. The red, green, and blue
distributions refer to the fraction of all NAGNAG boundaries splicing at the first NAG acceptor,
second NAG acceptor, and at both NAG acceptors respectively.
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2.2.12 Single amino acid insertions/deletions resulting from
the usage of NAGNAG acceptor splice sites do not
correspond to annotated protein functional residues
in FireDB
In our final analysis of NAGNAG tandem acceptor splice sites, we checked whether
these single amino acid insertions/deletions, which are introduced during alternative
tandem acceptor splice-site usage, map to annotated functional residues in proteins.
From our total NAGNAG mouse and human datasets, we extracted those cases in
which the spliceosome would be able to bind to either alternative acceptor splice site
with similar affinity. We took only those cases with log-likelihood differences between
−5 and 5. Then, we took only those sequences with coding sequence annotations and
subjected them to the following criteria: translational start codons at the beginning
of the extracted coding sequence, followed by no internal stop codons, and ending
with a translational stop codon. The filtering resulted in 273 human and 211 mouse
protein sequences containing a single amino acid insertion. We took these protein
sequences and used the Firestar tool to search FireDB (See literature review on
introduction to Firestar and FireDB), which is a database consisting of annotated
functionally important residues from proteins of known structure.
We have obtained very few hits for both mouse (2 matches) and human (3
matches) from FireDB and from these matches - after carefully assessing the scores -
we did not observe any biologically functional protein residue matches. Our deciding
factors for assessing good quality matches lies in two crucial factors: i.) functional
residue binding-site annotations which can come from two sources: a.) the number
of evolutionarily related sites, which gives an indication of the number of homologous
templates that bind to a particular ligand in equivalent positions as our template
and this value gives us an indication on the functional relevance of the amino acids
that are conserved between our template and other proteins and b.) binding-site
information from the Catalytic Site Atlas or literature, and ii.) the reliability scores,
which indicates how well we can transfer the binding-site annotations from our tem-
plate to our query sequence. The reliability scores are computed by Firestar, which
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uses SQUARE [76], which assigns reliability scores by extracting values for each
aligned residue from PSI-BLAST profiles pre-generated from the FireDB consensus
sequences. The SQUARE reliability scores provide information on which residues
are aligned reliably and can be used to infer sequence conservation. The lack of
biologically functional protein residue matches is primarily due to the low reliability
scores and the low number of homologous proteins having conserved amino acid
matches at our interested positions (See Table 2.2). Other factors that were taken
into account included the PSI-BLAST E-value and the fraction coverage, which is
the length of our query sequence matching to the template divided by the total
length of our query sequence.
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2.2.13 The frequencies of incontiguous NAG(X)nNAG mo-
tifs are not significantly higher in variant acceptor
splice sites compared to invariant splice sites
We next focused our attention to finding incontiguous NAG(X)nNAGs (where n >
0) that have significantly higher frequencies in variant acceptor splice sites com-
pared to invariant splice sites. The NAG(X)nNAG motif is observed in acceptor
splice sites when the first NAG acceptor is separated from the second NAG acceptor
by a certain number (n) of nucleotides. We first extracted all mouse exons that
show exon-length variation at their acceptor splice sites in coding sequence regions
(CDS) and then for each alternative exon, we extracted 45-nucleotide sequences,
consisting of 15 intronic and 30 exonic nucleotides from the splice boundary, and
then searched for NAG(X)nNAG patterns within these sequences. We searched for
the NAG(X)nNAG satisfying the following criteria: i.) the first NAG position in
an intronic position is kept while the second NAG acceptor is located within the
exonic portion, separated by a distance of n bases (up to a maximum of 12) ii.)
there are no other NAG motifs within the sequence between the first two NAGs.
For invariant splice sites, we applied the same procedure as described for variant
splice sites. The data obtained in this section utilizes the same number of mouse
full-length cDNAs (FANTOM3) as previously described, but they were mapped to
the mm7 genome assembly obtained from the University of California, at Santa Cruz
(http://hgdownload.cse.ucsc.edu/goldenPath/mm7/bigZips/).
The frequencies of NAG(X)nNAG motifs are presented in Table 2.3. We did not
find any NAG(X)nNAG motifs in the various distance categories (where n>0) that
have significantly higher NAG(X)nNAG frequencies in variant acceptor splice sites
when compared to invariant acceptor splice sites. In addition, NAG(X)nNAG motifs
occur at much lower frequencies when compared to the tandem NAGNAG motifs
in variant acceptor splice sites. This suggests that the tandem NAGNAG motifs
are specifically abundant to variant acceptor splice sites when we compare them to
NAG(X)nNAG-containing splice sites.
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Table 2.3: Counts of variant and invariant incontiguous NAG(X)nNAGs
n category
Variant CDS ex-
ons(% freq.)
Invariant CDS ex-
ons(% freq.)
p-values
0(NAGNAG) 561(25%) 4637(4.1%) <2.2e−16
1 83(3%) 5559(4.2%) 0.005
2 48(2%) 4850(4.4%) 3.2e−07
3 39(2%) 6484(5.9%) <2.2e−16
4 7(0.3%) 6660(6.02%) <2.2e−16
5 8(0.4%) 5732(5.2%) <2.2e−16
6 20(0.9%) 6393(5.8%) <2.2e−16
7 10(0.4%) 5253(4.8%) <2.2e−16
8 9(0.4%) 4381(4%) <2.2e−16
9 27(1.2%) 4547(4.1%) <7.18e−12
10 13(0.6%) 4102(3.71%) <2.2e−16
11 6(0.3%) 3468(3.14%) <2.2e−16
12 27(1.2%) 3666(3.32%) <3.8e−08
Total exon boundaries 2241 110581
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2.3 Discussion
Previously, the abundance of small (<10 nucleotides) exon-length variations at ac-
ceptor and donor splice sites has been reported by Zavolan et al. [49]. Interestingly,
we found that at acceptor splice sites, 58% of these small variations constitute in-
frame, variations that causes the length of an exon to increase or decrease by 3
nucleotides (3nt-variations). Even more intriguing is the fact that the abundance of
these 3nt-variations was not completely due to the effects of NMD, since we com-
puted the fraction of these variations before NMD and still found an abundance
of these 3nt-variations compared to other small exon-length variations of 1-4 nu-
cleotides. We thus conjecture that the abundance of these 3nt-variations is also
influenced in part by sequence biases that cause the spliceosome to ”slip” at neigh-
boring, competing splice sites.
Many of these 3nt-variations contain tandem NAGNAG motifs, but we did not
find evidence to support their functionality. For instance, we did not find evidence
of highly conserved NAGNAG motifs in mouse variant exons, quite on the contrary
- NAGNAG motifs were significantly more conserved in invariant exons. Moreover,
although we have observed a high frequency of NAGNAG motifs in variant CDS
exons, we found that the frequencies of NAGNAG motifs at the splice boundaries
of all noncoding exons were in fact significantly higher when compared to all coding
exons. Therefore, we conclude that the occurrence of NAGNAG motifs is not in-
dicative of their function in proteome diversification. We further suggested that the
observed variations at NAGNAG motifs are due to the stochasticity in spliceosome
binding.
We therefore wanted to compare the binding affinities of the spliceosome acting
on the NAGNAG acceptor splice sites. For this purpose, we used our WM model of
invariant acceptor splice sites to estimate the binding affinities of the spliceosome
splicing at the first and second NAG. We found that the likelihood difference between
the two NAGNAG sites is compatible with a model in which the spliceosome binds
stochastically at one or the other of the sites.
It is, however, possible that selection of a particular NAG can be driven by
specific factors affecting splice-site selection. But here in our study we show that
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based on sequence alone one can determine which NAG the spliceosome prefers and
that we can distinguish between variant and invariant NAGNAG acceptor splice
sites even when their polypyrimidine tracts have been extended. Our WM makes a
number of simplifications and it is possible that a more accurate model would be able
to quantitatively predict the relative usage of competing splice sites. For instance,
Tsai et al. showed that the sequence between the branchpoint and the NAGNAG
splice site as well as the nucleotide preceding the AG dinucleotide is important for
splice-site selection [99]. Refining the spliceosome-premRNA interaction model is
an interesting problem which can be addressed in future work.
Without deviating too much from the discussion of NAGNAG tandem acceptor
splice sites, we have found another use for our WM model - that is we were able to
use the probabilities computed from our donor and acceptor WMs to predict, with
reasonable accuracy, the relative frequencies of very small exon-length variations
of 1-4 nucleotides. The general order of predicted frequencies were similar when
compared to those observed distributions, except for the donor distributions in which
the predicted distributions of shifts of 1 and 4 nucleotides were slightly higher than
the observed fractions. Most importantly, predicted frequencies of 3nt-variations
were highly similar to their observed abundant frequencies before NMD. Thus, these
results further support our hypothesis that the abundance of small exon-length
variations must be due to the stochasticity in spliceosomal binding to closely spaced
splice sites.
The distributions of log-likelihood differences in fly and human are similar to
that in mouse suggesting that NAGNAG splice-site acceptors are quite common
and the spliceosomal mode of action - splicing only at the first NAG with higher
affinity, splicing only at the second NAG with higher affinity, and splicing at both
NAGs with roughly equal affinities - is also similar amongst the species examined.
The functional consequence of using NAGNAG acceptors is either the inclusion or
exclusion of a single amino acid. Hiller and others [94] proposed that a single amino
acid can increase the protein functional potential and we have tested this hypothesis
by taking those NAGNAG acceptors that have competitive binding affinities and
checked whether the single amino acid residues have good matches to functionally
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annotated protein residues in FireDB. We did not find any reasonable matches and
this indicates that there is no evidence so far to say that the inclusion or deletion of
the amino acid generally affects the function of proteins. Literature searches also fail
to reveal abundant evidence for functional NAGNAG single amino acid insertions
or deletions. Thus we conclude from our results that the majority of the NAGNAGs
do not contribute significantly to the protein functional diversity as proposed by
Hiller and others.
Our preliminary findings on incontiguous NAG(X)nNAG motifs, in which the
first NAG site is separated by a short distance to the second NAG site, has revealed
that NAG(X)nNAG motifs are present at lower frequencies in variant acceptor splice
sites when compared to the frequencies of tandem NAGNAG motifs in variant ac-
ceptor splice sites. Furthermore, they have significantly lower frequencies in variant
acceptor splice sites when compared to invariant acceptor splice sites suggesting that
the abundance of tandem NAGNAG motifs are specific to variant acceptor splice
sites.
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Chapter 3
Investigation into the dependency
of the inclusion/exclusion of
cassette exons on the transcription
start sites of their transcripts
3.1 Introduction/Rationale
The link between transcription and splicing is mediated by the C-terminal domain
of RNA polymerase II (RNA pol II). The C-terminal domain (CTD) is composed
of heptapeptide repeats containing the sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser, with
yeasts having 26 repeats and mammals 52. The serine residues in the repeats can
either have a low level of phosphorylation during or prior to transcription initiation
or a high level of phosphorylation after 25-30 nucleotides have been polymerized
and during transcription elongation. The function of CTD phosphorylation is to
enhance productive RNA pol II elongation (reviewed in Ref [101]).
Previously, two models of how transcription can affect alternative splicing have
been proposed: i.) The CTD of RNA pol II serves to recruit splicing factors, which
will influence splicing decisions downstream [102]. An example is the SRp20 protein,
which is recruited by RNA pol II and promotes exon-skipping of the fibronectin
cassette exon [103]. ii.) The rate of transcription elongation determines whether
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exons with weak splice sites are included (at low elongation rates) and skipped (at
high elongation rates) from the mature mRNA [104, 105]. There are some overlaps
between the two models proposed in which the components of the transcription
machinery modulates the RNA pol II elongation rate as well as interacting and
recruiting known splicing factors to the site of alternatively spliced exons. This can
be seen with the illustrated example of the alternative splicing of CD44 variant exons
(See Fig. 3.1), which is regulated by the BRM(Brahma) subunit of the SWI/SNF
chromatin remodeling complex [106].
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Figure 3.1: The BRM-regulated splicing of CD44 variant exons. The CD44 gene contains
ten clustered, variable exons with weak acceptor splice sites that are included or excluded during
splicing. The SWI/SNF complex is a chromatin remodeling complex, such that it regulates the
binding of transcription factors to DNA embedded in chromatin and it requires ATP in order
to alter the nucleosome structure. BRM, a subunit of the SWI/SNF complex, interacts with
Sam68, a factor that enhances the inclusion of exon v5 by binding to this exon. In addition,
BRM is also known to associate with other splicing factors. As shown in the figure, the combined
complex of BRM and SAM68 at the variant exonic region, may provide an entry point for incoming
spliceosomes or create an obstacle for RNA Pol II (bottom figure), and thus slowing the elongation
rate relative to the situation when BRM is lacking (top of the figure). The suggested role of BRM
is to reduce the processivity of RNA pol II by altering the CTD phosphorylation pattern. Figure
extracted from Auboeuf et al. [107].
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Here we have studied human and mouse internal cassette exons and have found
that their inclusion/exclusion from the mature mRNA frequently depends on the
transcription start site (TSS) used to generate their corresponding pre-mRNA. We
further show that those cassette exons that are strongly associated with their TSSs
may have been created recently.
3.2 Methods and Results
The work performed in sections 3.2.1 - 3.2.6 has already been published in the DNA
Research article entitled ’Computational analysis of full-length cDNAs reveals fre-
quent coupling between transcription and splicing programs’ and a copy is included
in Chapter 5. Please refer to the Materials and Methods section in the paper for a
detail description of sections 3.2.1 - 3.2.6.
3.2.1 Construction of TSS-associated,TSS-independent, and
constitutive exon datasets
We begin our analyses by first mapping mouse and human full-length transcripts to
their respective genomes and using our in-house splicing pipeline, SPAED, to obtain
4964 mouse and 11664 human internal cassette exons with no other splice variation
and these cassette exons are part of transcription units with multiple TSSs. We
defined our TSS quite conservatively as the initial exon of the transcript since the
position of the TSS can be variable [108]. Hence, different initial exons within a
transcription unit correspond to different TSSs. For each cassette exon and each
individual TSS we counted the number of times the cassette exon was included and
the number of times the exon was skipped when that particular TSS was used. We
then needed a method to quantify the coupling between the inclusion or exclusion
of the cassette exon and the usage of individual TSSs. The method we have used to
quantify such an association was developed by Professor Erik van Nimwegen and can
be briefly described as follows. We estimate the relative likelihood of two models,
a ”dependent” model, which assumes that there is a TSS-associated probablity for
the inclusion of the cassette exon, and an ”independent” model which assumes that
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the frequency of exon inclusion is the same for all TSSs. Using this model (given in
detail in Chern et al. [109]), we estimated that the fraction of mouse and human
internal cassette exons whose inclusion is dependent on the TSS is 24% and 30%
respectively. We further compute for each cassette exon the posterior probability
that its inclusion is dependent on the TSS. We then obtained cassette exons whose
posterior probabilities were either within the top or bottom 10%. We will refer to
those cassette exons that are within the top 10% as ’TSS-associated’ exons and the
bottom 10% as the ’TSS-independent’ exons. For mouse, we have obtained 496 TSS-
associated and TSS-independent exons and for human, we obtained 1166 cassette
exons in each of the two categories.
We further obtained 5136 mouse and 6377 human internal exons that were not
annotated with any splice variation and were included in more than 10 transcripts
as constitutive exons whose properties we wanted to compare to those of TSS-
associated and TSS-independent exons.
3.2.2 Comparisons of sequence features between TSS exons
and constitutive exons
In Table 3.1 (see below), we have summarized the sequence features that were
compared between TSS exon types (TSS-associated and TSS-independent) and
constitutive exons. For sequence conservation, we have used the UCSC pairwise
genome alignments to obtain orthologous regions for both mouse and human TSS
exon types and constitutive exons. We have also checked the fraction of exons
conserved over some percentage thresholds (>=50%,>=80%). We observed that
in general (for both human and mouse) TSS-independent and constitutive exons
have significantly higher conservation levels than TSS-associated exons (mouse p-
values=0.0007,<2.2e−16;human p-values=1.1e−06,<2.2e−16), with constitutive exons
having the highest conservation level.
We have also examined the inclusion rate, which is the total number of transcripts
that include the exon-of-interest divided by the total number of transcripts that
span the exon-of-interest. We have found that the TSS-associated exons have lower
average inclusion rates than the other exon types. We observed similar average
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inclusion trends between human and mouse.
We further examined the proportion of symmetrical exons (i.e. exons whose
length is a mutiple of 3) and found that this proportion is lower for TSS-associated
exons compared to TSS-independent exons (for mouse p-value=0.097, for human
p-value=0.072). However, the symmetrical exon proportions for constitutive exons
were even lower when compared to TSS-associated exons, but this difference was
only significant for human exons (p-value=0.02). Once again, we have observed
similar trends of symmetry in our mouse and human data.
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3.2.3 Weak correlation between the posterior probabilities
of orthologous, TSS-associated human and mouse ex-
ons
To obtain orthologous mouse and human exons, we used genome sequence align-
ments. We started with our query mouse TSS-associated exons and obtained the cor-
responding human exons using our genome alignments obtained from the University
of California (http://hgdownload.cse.ucsc.edu/goldenPath/mm7/vsHg18/axtNet/).
We also obtained the genomic coordinates of these human exons and matched
them to our dataset of human TSS-associated exons (described in the previous sec-
tion) to identify orthologous TSS-associated exons. This procedure was performed
in the same way starting from human TSS-associated exons and using genome
alignments from University of California to obtain our corresponding mouse exons
(http://hgdownload.cse.ucsc.edu/goldenpath/hg18/vsmm7/axtNet/). An ortholo-
gous pair of TSS-associated exons is defined as a pair of orthologous human and
mouse exons which were both considered TSS-associated. We plotted the poste-
rior probabilities of 668 mouse-human orthologous pairs and have observed a weak,
significant correlation (p-value=0.002) between mouse and human TSS association
(See Fig. 3.2).
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Figure 3.2: Correlation between the posterior probabilities of TSS association for
orthologous human-mouse cassette exons. Each dot refers to a human-mouse orthologous
pair, with the posterior probability of TSS-association of the mouse exon on the y-axis and of the
human exon on the x-axis. We have computed the correlation coefficient to be 0.12, p-value =
0.002. Figure taken from Chern et al. [109].
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3.2.4 Distance to the TSS is not predictive for the inclusion
or for the exclusion of TSS-associated exons
We questioned whether TSSs that are closer to the TSS-associated cassette exons
tend to promote inclusion and those that are far, promote exclusion, or vice versa.
We performed this experiment by first calculating the distance between cassette exon
and their TSSs. We define those TSS that promote the inclusion of the cassette exon
as ’inclusion-promoting TSS’ and those TSSs that promote the skipping of the cas-
sette exon as ’skipping-promoting TSS’. We then computed the average distance
to an inclusion-promoting TSS by summing the distances for all transcripts that
included the cassette exon for each TSS and dividing this number by the total num-
ber of transcripts that include the cassette exon. We perform the same procedure
for computing the average distances to skipping-promoting TSSs. We then took the
logarithm of the difference between the inclusion-promoting and skipping-promoting
average distances for each TSS-associated exon, and constructed a histogram from
these distances for mouse and human (See Fig. 3.3).
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Figure 3.3: Histogram of the signed difference between the logarithm (base 10) of the
inclusion-promoting and skipping-promoting average distances. The histograms shown in
black and red represent the human and mouse TSS-associated exons respectively. The distribution
on the right indicates when the average distance to the inclusion-promoting TSS is larger than
the distance to the exclusion-promoting TSS, and the left distribution indicates that the average
distance to the inclusion-promoting is smaller than the distance to the exclusion-promoting TSS.
Figure taken from Chern et al. [109].
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3.2.5 The frequency of the inclusion and exclusion of TSS-
associated exons occurring within the same tissue is
between 14-21% in mouse and human
One mechanism in which the inclusion and exclusion of TSS-associated exons can
occur is via the regulation by tissue-specific factors. Our goal for this experiment
is to estimate the frequency of TSS-association cases in which the transcripts that
includes or excludes the TSS-associated exons are expressed within the same tis-
sue, thus ruling out the possibility of tissue-specific regulation. We collected the
transcripts for each TSS-associated exon and obtain their tissue annotations from
GenBank. We have obtained 14% (58/419) and 21% (223/1042) of mouse and hu-
man TSS-association cases respectively.
3.2.6 The strength of the splice sites flanking TSS cassette
exon types does not agree with the kinetic model of
transcription-coupled splicing
According to the second proposed model of transcription-coupled splicing (the ki-
netic model), when cassette exons are flanked by weaker splice sites compared to
their flanking exons, then they may be skipped unless the polymerase elongation
rate is sufficiently slow to allow exon recognition by the spliceosome. We have
tested this hypothesis by examining the splice-site strengths of all exons in our
datasets. We have extracted the acceptor and donor splice sites flanking all TSS
cassette exon types (referred to as ”central exons” in Table 3.2) and their flanking
exons (referred to as ”upstream and downstream exons” in Table 3.2). We have
also extracted a reference dataset composed of constitutive exons for comparison.
We used a webserver (http://ast.bioinfo.tau.ac.il/SpliceSiteFrame.htm), which im-
plements the Shapiro and Senapathy model [110], to calculate the strengths of the
splice sites in our datasets. Table 3.2 shows the computed mean splice-site scores
for each category of exons.
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Table 3.2: Mean splice-site scores of TSS exon types and constitutive exons
Exon
types
Human Mouse
Acceptor splice site of central exon
TSS-associated 81.2 80.0
TSS-independent 81.6 81.8
constitutive 79.7 82.7
Acceptor splice site of upstream exon
TSS-associated 73.7 71.7
TSS-independent 78.1 79.4
constitutive 77.5 77.2
Acceptor splice site of downstream exon
TSS-associated 81.1 80.5
TSS-independent 80.6 81.7
constitutive 81.3 83.2
Donor splice site of central exon
TSS-associated 80.5 78.5
TSS-independent 80.3 77.5
constitutive 81.5 79.2
Donor splice site of upstream exon
TSS-associated 79.9 75.3
TSS-independent 80.9 79.3
constitutive 81.3 83
Donor splice site of downstream exon
TSS-associated 76 73.5
TSS-independent 73.8 73
constitutive 77.3 83.2
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From Table 3.2, we summarize our findings as follows:
1.) For TSS-associated exons in human and mouse, we did not observe that their
donor and acceptor splice-site strengths of their flanking exons were stronger than
the splice-site strengths of their central cassette exons. In fact, the donor and accep-
tor splice-site strengths of their flanking exons were similar or significantly weaker
(human upstream acceptor p-value=6e−07, mouse upstream acceptor p-value=4e−04,
human downstream donor p-value=0.0 2) than their central exons. Thus, our results
do not meet the requirements of the kinetic model.
2. We did not find any significant differences in the acceptor and donor splice-
site strengths between TSS-associated and TSS-independent groups of their central
exons.
3. In most cases, the acceptor and donor splice-site strengths of constitutive
exons were stronger than their TSS exon types, which was expected.
3.3 Discussion
In this study, we have characterized the sequence properties of TSS-associated exons
compared to other exon types. The lesson we have learned from comparing various
sequence features between TSS exons and constitutive exons is that TSS-associated
exons may have been created recently given their lower conservation levels and aver-
age inclusion rates compared to other exon types. Furthermore, the weak correlation
between the posterior probabilities of mouse and human TSS-associated, ortholo-
gous pairs suggest that the inclusion of cassette exons may depend on factors that
change on fast evolutionary timescales. On the other hand, it is clear that more
data is necessary in order to make definite statements about the TSS-dependence
of orthologous exons.
One proposed mechanism (also known as the kinetic model) in how transcription
affects alternative splicing involves the elongation rate of RNA polymerase and the
strength of the splice sites. Kornblihtt [104] proposed that if an alternative exon
has a weak acceptor splice site, then a fast-elongating polymerase would lead to its
skipping and a slower one would lead to its inclusion. Based on our observations that
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the splice sites of our TSS-associated exons have comparable or stronger splice-site
strengths compared to their upstream and downstream exons, we conclude that the
TSS-dependency of our exons cannot be explained by the kinetic model.
The fact that RNA polII appears to pause at the 5′ region of the transcription
units of genes [111, 112, 113, 114] during early transcription elongation led us to
question whether the TSS-associated exons could be explained by this process. That
is, we asked whether the majority of TSS-associated exons are included when the
most proximal promoters are used and skipped when the most distal promoters are
used. We found that the proportion of those TSS-associated exons that were pref-
erentially included when the most upstream TSSs were used (where Di < Ds) was
similar to the proportion of TSS-associated exons that were preferentially included
when the most downstream TSSs (where Di > Ds) were utilized. Thus we cannot
explain their inclusion by the RNA polymerase pausing at 5′ ends of transcripts.
A second mechanism that could explain the TSS-association could involve tissue-
specific factors that play a role in tissue-specific transcription and tissue-specific
splicing. By filtering for only those TSS-associated exons for which the transcripts
that validate the exon inclusions and exclusions were expressed in the same tissue,
we can rule out the possibility that only tissue-specific factors regulate transcription
and splicing. We have found that approximately 14-21% of mouse and human TSS-
cassette exons have their inclusions/exclusions expressed in the same tissue and thus
conclude that at least for some of these exons, alternative splicing is likely to be
regulated through direct coupling of transcription and splicing events. In addition,
if one were to further study experimentally the mechanism of TSS-dependency of
cassette exons, we would recommend using this particular subset of TSS-associated
exons.
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A first look at mutually dependent
and mutually exclusive splicing
events in silico
4.1 Introduction/Rationale
Mutually exclusive (ME) splicing describes the situation when alternatively spliced
exons are never found together in the same transcript. This alternative splicing
pattern appears to be quite common in receptor and channel subunits (fibroblast
growth factor receptor 2 [115], glutamate receptor subunits 1-4 [116], sodium chan-
nel alpha subunit [117], calciumvL-type channels [118]), in structural proteins (C.
elegans let2 gene [119], alpha and beta tropomyosins [120]), and they are also found
in the muscle protein subunits such as the Troponin T subunit [121]. The mutually
exclusive splicing found within these genes typically results in developmentally- or
tissue-specific isoforms. In mammalian genes, we often observe two ME exons in-
volved in the ME splicing, whereas in Drosophila, the process appears to be far more
complex. The well-known Dscam gene in Drosophila can give rise to over 38000 dif-
ferent alternatively spliced transcripts. The splicing of Dscam is achieved through
the alternative splicing of one alternative exon from each of the four available exon
clusters, with each cluster containing ME exons (See Fig 4.1).
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Figure 4.1: Mutually exclusive splicing of the Dscam gene. Only one exon from each
of the alternative exon clusters, which are shown in the different colors, are included in the final
mRNA transcript. Figure extracted from Wojtowicz et al. [122].
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The RNA-binding protein asd-2 is responsible for regulating the ME splicing of
the let-2 gene in C. elegans [123], whereas in the Drosophila Dscam gene, it is the
combination of a splicing repressor, hrp36, and alternative RNA structures that are
regulating the alternative splicing[124].
The current study is focused on groups of consecutive cassette exons (more than
one) that are always either skipped or included together within transcripts, which
we define as ”mutually dependent” exons (MD). This kind of splicing have not been
previously described in literature as a separate form of alternative splicing, thus
this is the first known study to characterize the properties of MD exons relative
to ME and constitutive exons. In addition, no large-scale computational study
has so far examined mutually exclusive splicing in both mouse and human genomes,
although this type of splicing does exist as we have seen from our literature examples
described above. Our preliminary analyses of MD and ME splicing in mouse and
human, revealed subtle differences in the features of the two types of exons, which
may prove to be useful for future MD and ME studies.
4.2 Methods and Results
4.2.1 Transcript mapping and alternative splicing annota-
tions
We have used full-length mouse and human cDNAs and have mapped these tran-
scripts to their respective genomes using our in-house splicing pipeline, SPAED. The
alternative splice annotations were retrieved from our mouse and human full-length
database generated for the studies in Chapters 2 and 3. The procedure for mapping
and obtaining our splice variations are also the same as described in the previous
chapters.
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4.2.2 Comparison of symmetry, exon- and intron-lengths,
and sequence conservation between the different cas-
sette exon types and constitutive exons
We define an ME exon cluster as consecutive cassette exons that are observed to
be skipped, but are never found together on the same transcript. Similarly, an MD
exon cluster is defined as a group of consecutive cassette exons that are always in-
cluded or skipped together within the same transcript. We have obtained 60 ME
and 221 MD examples for mouse, and in human, we have obtained 91 ME and 382
MD examples. The total number of ME and MD exons in mouse was 120 and 520
respectively, and in human - we obtained 183 ME and 896 MD exons. We have also
obtained groups of consecutive cassette exons that do not correspond to either of
the ME and MD type, which we have defined as a ’mixed’ exon cluster. We have
obtained 19 (38 exons in total) and 51 (103 exons) such cases in mouse and human
respectively. For constitutive exons, we have retrieved internal exons with no splice
variation and have obtained 102083 mouse and 123467 human exons. For all exon
types (ME, MD, constitutive, and mixed), we have computed the proportion of ex-
ons and introns whose length is a multiple of 3. We determined the sum of all exon
lengths within an ME, MD, constitutive, and mixed cassette exon cluster and the
length of intron between the exons present within each ME, MD, mixed, and consti-
tutive exon cluster. The human-mouse and mouse-human orthologous alignments
were extracted for all exons within the ME, MD, and mixed exon clusters, using
human and mouse whole-genome alignments obtained from the University of Cal-
ifornia, at Santa Cruz (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/vsMm8/
and http://hgdownload.cse.ucsc.edu/goldenPath/mm7/vsHg17/). We then filtered
the alignments that have a percentage identity of greater or equal to 85% to obtain
our fraction of highly conserved exons. The results are summarized in Table 4.1
below.
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Although the proportions of symmetrical exon clusters were not significantly
different between mouse ME and MD exons (p-value=0.08), the expected trend that
this proportion was higher in MD than in ME exons was observed. In human, the
proportion of symmetrical exon clusters was significantly higher in MD compared
to ME exons as expected (p-value=0.0006) and also to constitutive exons (human
p-value=0.0001). The latter comparison also gave a significant difference in mouse
(p-value=1.53e−06). However, comparisons of MD exons to mixed cases did not yield
any significant differences in either of the species which suggest that the pressure of
maintaining the exon reading frame in mixed cases may be similar to MD exons.
Although the proportions of individual symmetrical ME exons were not signif-
icantly higher than MD exons, the higher proportion observed for ME exons was
expected and we can see this trend more clearly in mouse. Both human and mouse
proportions of individual symmetrical exons were significantly lower than the pro-
portions of mixed exons (Human p-value=0.0003,mouse p-value=9e−06). However,
comparisons to constitutive exons did not reveal any consistent trends.
We have found that human MD exon clusters contain significantly shorter in-
tron lengths compared to the intron lengths in other exon cluster groups (ME exon
clusters p-value=0.01; constitutive exon clusters p-value=0.003; mixed exon clusters
p-value=0.006). The trend is similar in mouse, but only significantly shorter when
compared to constitutive exon clusters (p-value=0.03). When we focused only on in-
tron lengths less than 40 kilobases(kb) between ME and MD groups, we still observe
the same trend in both species, but with no significance in either of the species. This
suggests that extremely large intron lengths were present in the human ME dataset,
however the trend that MD exon clusters have shorter intron lengths compared to
other datasets still remains.
Since we have observed significantly shorter intron-lengths in human MD exon
clusters compared to other exon groups, we have examined their intron-length dis-
tributions more closely (See Fig. 4.2).
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Figure 4.2: Distribution of intron length for MD (green), ME (pink), and constitutive
(black) exon clusters
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Comparison of the human MD intron-length distribution to the ME intron-length
distribution was found to be significant according to the kolmogorov-smirnov test (p-
value= 0.0008) and comparisons to other distributions did not yield any significance.
We have observed the same trends in mouse and human that ME exons have
the largest exon lengths, followed by constitutive, MD, and mixed exons. However,
ME exon lengths were not significantly larger than MD exon lengths. Comparisons
of MD exon lengths to other exon types yielded significance in mouse (constitutive
p-value=3.65e−11, mixed p-value=0.002). Lastly, we did not observe a consistent
trend in the conservation pattern of the different categories of exons except that the
proportion of highly conserved exons was highest in the mixed exon category.
4.3 Discussion
Our analysis of MD and ME exons revealed that the properties of these exons
matched our expectations. The proportion of symmetrical exon clusters was higher
in MD exons than in ME exons since MD exons are always included or excluded
together and not independently of each other. Conversely, we did observe higher
proportion of symmetrical ME individual exons since they are individually included
and excluded and never occur together.
Interestingly, we observed that the average intron length between the individual
exons in MD clusters was smaller than in ME clusters. We envision several possible
explanations: i.) the inclusion and exclusion of the individual exons within the MD
cassette are dependent upon each other and the shorter intron length may facilitate
the loading of the spliceosome at consecutive downstream introns, ii.) long introns
may result in high rates of RNA polymerization and poor exon recognition during
co-transcriptional splicing.
The relatively small number of these various exon categories made it difficult to
infer statistically significant differences in their properties. Nonetheless, we were able
to draw some conclusions about their symmetry and about the lengths of introns in
these exon clusters. These conclusions can be interpreted in light of the mechanism
of splicing of these exons and we therefore believe that our study provides a good
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basis for follow-up studies of MD exon clusters.
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Publications
The following publications for chapters 2 and 3 are included in this section.
5.1 Publication for Chapter 2
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One of the most common splice variations are small exon length variations caused by the use of alternative donor or
acceptor splice sites that are in very close proximity on the pre-mRNA. Among these, three-nucleotide variations at so-
called NAGNAG tandem acceptor sites have recently attracted considerable attention, and it has been suggested that
these variations are regulated and serve to fine-tune protein forms by the addition or removal of a single amino acid.
In this paper we first show that in-frame exon length variations are generally overrepresented and that this
overrepresentation can be quantitatively explained by the effect of nonsense-mediated decay. Our analysis allows us
to estimate that about 50% of frame-shifted coding transcripts are targeted by nonsense-mediated decay. Second, we
show that a simple physical model that assumes that the splicing machinery stochastically binds to nearby splice sites
in proportion to the affinities of the sites correctly predicts the relative abundances of different small length variations
at both boundaries. Finally, using the same simple physical model, we show that for NAGNAG sites, the difference in
affinities of the neighboring sites for the splicing machinery accurately predicts whether splicing will occur only at the
first site, splicing will occur only at the second site, or three-nucleotide splice variants are likely to occur. Our analysis
thus suggests that small exon length variations are the result of stochastic binding of the spliceosome at neighboring
splice sites. Small exon length variations occur when there are nearby alternative splice sites that have similar affinity
for the splicing machinery.
Citation: Chern TM, van Nimwegen E, Kai C, Kawai J, Carninci P, et al. (2006) A simple physical model predicts small exon length variations. PLoS Genet 2(4): e45. DOI: 10.
1371/journal.pgen.0020045
Introduction
Anticipating that the sequencing and initial annotation of
the human [1,2] and mouse [3] genomes will not be able to
uncover all the complexities of mammalian gene structures,
several groups have focused on producing high-quality,
annotated transcript data such as the Riken Clone Collection
[4,5], the Mammalian Gene Collection [6], the NCBI Refer-
ence Sequence [7], and the NCBI unfinished high-throughput
cDNA sequences. In conjunction with genome sequences,
these data have revealed that alternative splicing [1,8–11],
alternative transcriptional initiation, and alternative poly-
adenylation [5,12,13] are extremely common, affecting over
70% of mammalian genes [14].
Many factors at the molecular level appear to play a role in
the regulation of splicing, from the recognition of the
primary splice signals by the components of the spliceosome,
to modulation of splicing via interactions of signaling and
RNA processing pathways with the spliceosome. More
specifically, the choice of splice site appears to be determined
by a combination of (1) the strength of the splice signal, i.e.,
the affinity for the splicing machinery of the sequence around
the splice site, (2) structural constraints set on the inter-
actions of spliceosomal components by the lengths and
sequences of introns and exons and possibly by the secondary
structure of the mRNA, (3) the presence of enhancer or
repressor elements that may serve, respectively, to activate a
weak splice site or repress a strong one, and (4) the effective
concentrations of splicing factors such as SR proteins and
heterogeneous nuclear ribonucleoproteins that can be
regulated through post-translational modifications such as
phosphorylation [15]. The extensive literature elaborating on
the mechanisms of repression and activation of specific splice
sites has been reviewed by Smith and Valcarcel [16] and more
recently by Matlin et al. [17].
The high estimates of the frequency of alternative splicing
in human [8,14,18] and mouse [13] genes raise the question to
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what extent these splice variations are functional, with their
production controlled and regulated by the cell, versus being
the result of inherent noise in the molecular process of
splicing. The molecular mechanisms mentioned in the
previous paragraph are all susceptible to noise, e.g., thermo-
dynamic noise, fluctuations in the concentrations of splicing
factors, fluctuations in elongation rates, and any other
fluctuations that are not under the control of the cell. It is
thus clear that some of the splice variation observed in the
sequence data might simply be a result of noise [19]. At the
same time, one can easily imagine that many of the molecular
mechanisms just mentioned could be exploited by the cell to
regulate the expression of different splice variants under
different conditions.
In a previous study [13], we found that the second most
common form of splice variation (after ‘‘cassette’’ or
‘‘alternative’’ exons that are included in some but not all
transcripts) is a small change in exon length due to the use of
closely spaced alternative donor or acceptor sites. Intuitively,
the simplest explanation for these abundant small exon
length variations is that they are a result of noise in the
splicing process that causes the spliceosome to ‘‘slip’’ by a
small number of nucleotides, perhaps to a competing
neighboring splice site. However, as we previously reported
[13], three-nucleotide variations at tandem acceptor sites are
by far the most common among these small exon length
variations, and are much more common than any other exon
length variation. This seems to suggest that processes other
than simple noise must be causing these small in-frame shifts.
Indeed, in this context Hiller et al. [20] have proposed an
intriguing hypothesis, namely, that splice variations involving
only three nucleotides at so-called NAGNAG tandem accept-
or sites are introduced in a regulated manner to ‘‘fine-tune’’
the protein sequence. More recently, these three-nucleotide
splice variations at NAGNAG sites have attracted consider-
able attention [21], including two papers [22,23] that
appeared after our submission of the current work.
Here we extensively study the statistics of small exon length
variations. We revisit our original hypothesis that these small
exon length variations are a result of noise in the splicing
process. In particular, we show that a combination of the
effects of nonsense-mediated decay (NMD) and a simple
physical model of the splicing machinery binding in a
stochastic manner to nearby splice sites can efficiently
explain all the observed statistics. In addition, we show that
our physical model can predict which NAGNAG tandem
acceptor sites are likely to undergo alternative splicing, which
will splice exclusively at the first NAG, and which will splice
only at the second NAG.
Results
Splice Variations at Acceptor and Donor Sites
The use of alternative splice donor and acceptor sites leads
to exons whose length varies between transcripts. By far the
most common variation of this kind is a difference of precisely
three nucleotides at acceptor sites. To investigate the origin of
such variations we selected all exons that showed variation at
only one of their two splice sites, i.e., only at their acceptor site
or only at their donor site. For each exon with an alternative
acceptor (or donor) site we chose the most common splice site
as a reference site and counted the total number of alternative
splice events at different distances from the reference site.
Figure 1 shows the distribution of distances for both acceptor
and donor sites, calculated separately for coding, untranslated
region (UTR), and noncoding exons.
The first thing to note is that the total number of
alternative acceptor sites is larger than the overall number
of alternative donor sites. This observation is consistent with
our previous reports on the FANTOM2 dataset [13] as well as
Figure 1. The Number of Splice Events Involving Alternative Donor and Acceptor Sites at a Specified Distance Relative to the Reference (Most
Commonly Used) Splice Site
The horizontal axis shows the distance from the reference splice site corresponding to each genomic exon for both donor sites (left) and acceptor sites
(right). The red lines correspond to coding exons, the black lines to UTR exons, and the blue lines to exons from non-protein-coding transcription units.
The vertical axis is shown on a logarithmic scale.
DOI: 10.1371/journal.pgen.0020045.g001
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Synopsis
It has recently become clear that splice variation affects most
mammalian genes. It is, however, less clear to what extent these
splice variations are functional and regulated by the cell as opposed
to simply a result of noise in the splicing process.
One of the most frequently observed forms of splice variation are
small variations in exon length in which the boundary of an exon is
shifted by small amounts between different transcripts. In this work
the authors study the statistics of these splice variations in detail,
and the results suggest that these variations are mostly the result of
noise in the splicing process. In particular, they propose a simple
physical model in which the last step of splicing involves the
sequence-specific binding of the splicing machinery to the splice
site. In this model, small length variations can occur when there are
nearby splice sites with comparable affinity for the splicing
machinery. The authors show that this model not only accurately
predicts the relative abundances of different splice variations but
also predicts which splice sites are likely to undergo small exon
length variations.
with the observation made by Sugnet et al. [24] that conserved
mouse and human alternative acceptor splice sites are twice
as common as conserved alternative donor splice sites.
The second thing to note is that small length variations are
very common: 23.7% of all donor site variations and 43.7% of
all acceptor site variations involve ten or fewer nucleotides.
This is suggestive of a ‘‘noise’’ process in which the spliceosome
‘‘slides’’ a few nucleotides from its initially chosen position.
Preference for Reading Frame Preservation and NMD
Most of the exon length variations shown in Figure 1 are
not a multiple of three in length, and would therefore have
dramatic effects on translation whenever the splice boundary
overlaps the coding region (CDS). We will refer to exon
length variations as ‘‘in-frame’’ and ‘‘frame-shifting’’ depend-
ing on whether the change in exon length is or is not a
multiple of three. Figure 2 shows the fraction of in-frame and
frame-shifting variations for each category of splice sites. We
see that in-frame variations are overrepresented at the
acceptor boundaries of all exon types. In contrast, in-frame
variations are overrepresented at donor sites only of CDS
exons, and they amount to roughly 1/3 of the variations at the
donor sites of UTR and noncoding exons.
The different behavior of donor and acceptor sites is the
result of the very different distribution of very small exon
length variations of 1–4 nucleotides. As we show in detail
below, the frequencies of these very small exon length
variations at acceptor and donor sites are the result of the
different sequence composition of the first few intronic bases
at donor and acceptor sites. If we focus on exon length
variations of more than four nucleotides, we find that,
strikingly, both donor and acceptor splice sites show the
same pattern of in-frame variation across exon types (Figure
3). Namely, the frequency of in-frame variations at both
donor and acceptor splice sites of noncoding and UTR exons
is statistically indistinguishable from 1/3, which is what one
would expect by chance. Moreover, CDS exons show the same
overrepresentation (approximately 48%) of in-frame varia-
tions at both donor and acceptor splice sites.
One possible explanation for the overrepresentation of in-
frame variations could be that the sequences flanking CDS
exon boundaries are biased such that alternative splice sites
occur more often in frame than out of frame. To test this
hypothesis we extracted the 100 nucleotides of the intronic
sequence flanking the acceptor splice site of each exon that
shows length variation at the acceptor boundary and counted
the number of times an AG dinucleotide occurs at different
distances from the boundary. Similarly, we counted the
number of times the dinucleotide GT occurs at different
distances from donor sites of exons that show variation at
their donor site. We then determined the fraction of times
AG and GT occur in frame relative to the acceptor and donor
splice sites, respectively. The results are shown in Figure 4.
We see that, for both donor and acceptor sites, and for all
exon types, the frequency of in-frame occurrence of
dinucleotides that could form alternative splice sites is very
close to 1/3. It thus appears that biases in the sequence
composition flanking CDS exons cannot explain the over-
representation of in-frame exon length variations at either
donor or acceptor sites.
The most plausible explanation for the statistics of the in-
frame variations is that NMD removes a fraction of tran-
scripts that have frame-shifting exon length variations in CDS
exons. The details of the NMD process are not completely
understood, but it is generally thought to function as follows
[25,26]. After the splicing process, the exon junction
complexes remain attached and are carried along with the
transcript. During a preliminary round of translation these
complexes are removed by the translation machinery. If any
Figure 2. Proportion of In-Frame Variations at Donor and Acceptor Splice
Sites That Are Located within CDS, UTR, and Noncoding Regions
This figure shows the fractions of alternative splice events that lead to an
in-frame shift with respect to the reference boundary at acceptor (39) and
donor (59) splice sites of CDS, UTR, and noncoding (NC) exons. The
estimated fraction is in the middle of the gray bar, with the gray bar
indicating two standard errors. The dashed line shows the fraction 1/3
that would be expected by chance.
DOI: 10.1371/journal.pgen.0020045.g002
Figure 3. Proportion of In-Frame Variations of More Than Four
Nucleotides at Donor and Acceptor Sites Located within CDS, UTR, and
Noncoding Regions
This figure shows the fractions of alternative splice events that lead to an
in-frame shift with respect to the reference boundary at acceptor (39) and
donor (59) splice sites of CDS, UTR, and noncoding (NC) exons, when only
splice events that are more than four nucleotides shifted with respect to
the reference boundary are considered. The two rightmost columns
show the fractions when the data from all CDS exons and all non-CDS
exons are pooled.
The estimated fraction is in the middle of the gray bar, with the gray bar
indicating two standard errors. The dashed line shows the fraction 1/3
that would be expected by chance.
DOI: 10.1371/journal.pgen.0020045.g003
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such complex remains further than some critical distance
away from the stop codon, the transcript is targeted by NMD.
Thus, frame-shifting length variation in CDS exons leads to
premature stop codons, which in turn increase the chance of
the transcript being targeted by NMD. In contrast, the
boundaries of noncoding and UTR exons already do not
overlap the CDS; therefore, the shifts that occur here do not
alter the probability of the transcript being targeted by NMD.
In summary, it is reasonable to assume that some fraction
of all frame-shifting exon length variations at CDS exons are
targeted by NMD, and that only a fraction f survive NMD. Let
us assume that before NMD a fraction qi of all exon length
variations at CDS exons are in frame. Since in-frame exon
length variations are not affected by NMD, and a fraction f of
frame-shifting variations make it past NMD, it follows that
the observed frequency qo of in-frame exon length variations
in CDS exons is given by
qo ¼
qi
qi þ f ð1 qiÞ
: ð1Þ
There is no reason to believe that the fraction qi of in-
frame variations before NMD is different from 1/3. This
assumption is supported by the fact that the fraction of
potential acceptor and donor dinucleotides within 100
nucleotides of exon boundaries is 1/3 for both CDS and
non-CDS exons (see Figure 4). We thus assume that qi ¼ 1/3
for CDS exons as well. Since qo ¼ 0.484 (Figure 3) for CDS
exons, it then follows that f ¼ 0.53. That is, the data suggest
that slightly more than 50% of the transcripts that contain a
frame-shifting exon length variation in a CDS exon survive
the NMD process.
Exon Length Variations of 1–4 Nucleotides and NAGNAG
Acceptor Boundaries
We now turn to the exon length variations of 1–4
nucleotides, whose relative frequencies are shown in Figure
5. To take into account the effects of NMD we have rescaled
the numbers of variations of length three by a factor f¼ 0.53,
as calculated in the previous section. Moreover, since the
frequencies of such variations at CDS, UTR, and noncoding
exons are very similar, we have pooled the data for each type
Figure 4. Proportion of Putative Donor (GT) and Acceptor (AG) Splice
Sites That Are Located In-Frame Relative to the Splice Sites in CDS, UTR,
and Noncoding Regions
This figure shows the fraction of AG dinucleotides that occur at distance
that is a multiple of three in the first 100 intronic bases upstream of
acceptor (39) splice sites of exons that show splice variation at their
acceptor sites, and the fraction of GT dinucleotides that occur at a
distance that is a multiple of three in the first 100 intronic bases
downstream of donor (59) splice sites of exons that show splice variations
at their donor sites. Occurrences of AG or GT within the first four bases
flanking the splice sites were not counted. The estimated fraction is in the
middle of the gray bar, with the gray bar indicating two standard errors.
The dashed line shows the fraction 1/3 that would be expected by chance.
DOI: 10.1371/journal.pgen.0020045.g004
Figure 5. The Distribution of Alternative Splice Events That Are Shifted by One, Two, Three, or Four Nucleotides with Respect to the Reference Splice
Site
The two left panels show the observed distributions at acceptor sites (above) and donor sites (below). The estimated relative frequency is in the middle
of the gray bar, with the width of the gray bar corresponding to two standard errors. The panels on the right show the predicted relative frequency of
alternative splice events of lengths 1–4 based on the splice site WMs and the sequences around exon boundaries that show splice variation.
DOI: 10.1371/journal.pgen.0020045.g005
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of splice site (Table S1 lists these distributions separately for
each exon type). Figure 5 thus shows estimates of the relative
frequencies of splice variations of lengths 1–4 nucleotides
before NMD, which appear to be very different for donor
compared to acceptor splice sites. At donor sites, the most
common variations are shifts of one or four nucleotides while
in-frame variations of length three are rare. In contrast, at
acceptor sites the in-frame variations of length three are
highly overrepresented, as we have already reported in our
analysis of the FANTOM2 dataset [13]. The very large
majority (94%) of these three-nucleotide variations involve
tandem acceptor sites whose sequence is of the form
NAGNAG. These have been the topic of a recent paper by
Hiller et al. [20], who proposed that the role of such variations
is to ‘‘fine-tune’’ protein forms by addition/deletion of a
single amino acid. That is, Hiller et al. [20] suggested that
these NAGNAG sites have been specifically selected to
provide the cell with alternative protein forms, and to
express these different protein forms in a regulated manner.
If the three-nucleotide variations at NAGNAG acceptor
sites were indeed important for fine-tuning protein forms,
then one would expect these variations to be more abundant
at CDS than at non-CDS exons. However, once we correct for
the overrepresentation of all in-frame variations due to NMD,
this is not what we observe. As shown in Table S1, the relative
frequency of three-nucleotide variations is not significantly
different at CDS, UTR, and noncoding exons. In addition, the
NAGNAG sequence motif is not overrepresented at acceptor
sites of CDS exons. On the contrary, the frequency of
NAGNAG sites at the splice boundaries of UTR and
noncoding exons is 6.7% compared to only 5.9% at the
boundaries of coding exons. This is statistically significantly
lower in a v2 test at a p-value of 0.00014. Thus, NAGNAG
sequences are in fact a little less frequent at the acceptor sites
of CDS exons than at those of non-CDS exons.
We next investigated the evolutionary conservation of
NAGNAG acceptor sites. If the NAGNAG sites that show
splice variation were explicitly selected to do so, one would
expect them to be better conserved evolutionarily than
NAGNAG sites in exons that show no splice variation. To test
this hypothesis, we extracted the human sequences that
correspond to NAGNAG sites in mouse from the pairwise
mm5–hg17 alignments provided by the University of Cal-
ifornia Santa Cruz Genome Bioinformatics group (http://
hgdownload.cse.ucsc.edu/goldenPath/mm5/vsHg17/axtNet).
We found that the proportion of mouse NAGNAG acceptor
sites that have corresponding human NAGNAG sites (allowing
the nucleotides at the N positions to vary) is in fact slightly
higher in invariant exons (59.5%) than in variant exons
(54.7%) (3,998/6,715 versus 273/499, v2 test, p ¼ 0.04). The
frequency of perfectly conserved NAGNAG sites (where the
nucleotides at theNpositions are conserved as well) is 45.7% in
invariant exons and 42.7% in variant exons, which statistically
is not significantly different. Thus, NAGNAG sites of variant
exons are not more conserved in evolution than NAGNAG
sites of invariant exons. If anything they are less conserved
than NAGNAG sites of invariant exons. We thus cannot find
any evidence that the abundance of three-nucleotide varia-
tions at acceptor sites is due to specific selection, or that it is
related to the coding potential of the transcript.
We instead consider the much simpler hypothesis that the
small exon length variations are a result of inherent noise in
the splicing process. We hypothesize that the final step in the
process of splice site selection involves the sequence-specific
binding of the splicing machinery to the mRNA. This binding
process is subject to thermal noise just like any physicochem-
ical process. Whenever multiple ‘‘binding sites’’ with com-
parable affinity occur near each other, the splicing machinery
may bind to these alternative sites in a stochastic fashion, and
this will lead to small shifts of the splice site.
To test this hypothesis we first constructed computational
models of the sequence specificity of the splicing machinery
at acceptor and donor sites. Specifically, we gathered
acceptor and donor boundaries of invariant exons and
reconstructed weight matrices (WMs) of length 12 from the
six intronic bases and the six exonic bases flanking each
boundary. These WMs are shown in Figure 6. The WMs
demonstrate the well conserved GT dinucleotide immediately
following the donor boundary and the AG dinucleotide
immediately preceding the acceptor boundary. The WMs also
show the known preference for a second GT dinucleotide
four nucleotides downstream of the donor site, the polypyr-
imidine tract 5–6 nucleotides upstream of the acceptor site,
and the preference for a cytosine immediately preceding the
AG of the acceptor site.
We now assume that the probability of the splicing
machinery binding to a particular sequence is proportional
to the probability of observing that sequence when sampling
from the WM representing that boundary. That is, we assume
that the probability P(i) that the splicing machinery will bind
Figure 6. WMs Representing the Sequence Specificity of the Spliceosome at Invariant Donor and Acceptor Splice Sites
WMs have been constructed from six exonic and six intronic nucleotides flanking each type of splice site. The relative sizes of the letters are
proportional to the frequency wa
i of each nucleotide a at position i. The total height in each column is given by the information score I¼Rawai log(4wai ).
DOI: 10.1371/journal.pgen.0020045.g006
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and splice at a particular location i is proportional to the
probability of the local sequence si6si5...siþ4siþ5 under theWM
PðiÞ ¼ P
k¼5
k¼6
wksiþk ; ð2Þ
where wka is the frequency of base a at position k of the WM,
and i is the location of the putative splice site.
For the donor site WM we collected all exons that show
variation at the donor site and calculated the probabilities P(i)
at the positions that are shifted by between one and four
nucleotides (either to the left or right) with respect to the
observed splice site. By summing all P(i) that correspond to
shifts of the same length, we calculated the relative frequencies
of length variations of lengths 1–4 that our model predicts.
These predictions are shown in the lower right panel of Figure
5. In the same way, using the acceptor site WM and the
sequences flanking acceptor sites in exons that show variation
at their acceptor site, we calculated the relative frequencies of
variations of lengths 1–4 that our model predicts at acceptor
sites. These predictions are shown in the upper right panel of
Figure 5. Given the simplicity of our model, its predictions of
the relative abundances of different length variations match
the data surprisingly well. At the donor sites, it correctly
predicts that shifts of length one and four are the most
abundant and that shifts of length three are the least
abundant. At the acceptor sites, the model predicts relative
abundances that are quantitatively very close to the observed
abundances. In particular, the predicted abundance of three-
nucleotide variations is within 1% of the observed abundance.
We thus see that a very simple model of splice site selection
based on the sequence specificity of the splicing machinery at
each splice site can correctly predict the relative abundances
of small exon length variations. This further supports the
hypothesis that these small exon length variations are mostly
the result of inherent noise in the splicing process.
Local Sequence Distinguishes Variant Tandem Acceptor
Sites from Nonvariant Tandem Acceptor Sites
If ourmodel for the small exon length variations is correct, it
should also be possible to predict, from the sequence, which
acceptor sites are most likely to be prone to three-nucleotide
length variations. To this end we focused on all acceptor sites
that show the sequence pattern NAGNAG at their splice site.
We collected all acceptor sites with sequence NAGNAG
(irrespective of which of the two NAG sequences is used as
splice site) and then selected only those sites forwhich there are
at least two transcripts in the data. We then counted, for each
NAGNAG site, howmany times we observed splicing at the first
and how many times at the second NAG site. Based on these
counts we separated the NAGNAG sites into three categories:
those that splice only at the first NAG, those that splice only at
the second NAG, and those that splice at both NAGs.
We then investigated to what extent we could predict the
category of each NAGNAG site by using the WM constructed
from the invariant acceptor sites. We again assumed that the
binding affinity of the splicing machinery to a putative
acceptor site sequence is proportional to the log-likelihood of
the putative acceptor site sequence given the acceptor site
WM. If we additionally assumed that the probability of
splicing occurring at the different NAG sites is proportional
to the equilibrium frequencies with which the splicing
machinery binds at these sites, then the category of a
NAGNAG site is only a function of the difference in log-
likelihood of the neighboring acceptor sites.
Figure 7 shows the fractions of NAGNAG sites that splice
only at the first NAG, only at the second NAG, or at both
NAGs as a function of the log-likelihood difference of the two
sites. The results are quite striking. We see that, using the
simple WM model, one can reasonably accurately predict
which NAGNAG sites splice only at the first NAG, which
splice only at the second, and which show three-nucleotide
length variations. Whenever the log-likelihood of the first site
is larger by five or more than the log-likelihood of the second
site, then splicing virtually always occurs at the first site only.
Similarly, if the log-likelihood of the second site is larger by
five or more than the log-likelihood of the first site, then
splicing virtually always occurs at the second site. When there
is almost no difference in the log-likelihood of the two sites,
then in the large majority of examples one observes splicing
at both sites. These results further support our hypothesis
that splice site selection is simply based on the affinity of the
splice site for the splicing machinery, and that small exon
length variations occur whenever there are neighboring
splice sites with comparable affinity.
Discussion
Recent large-scale sequencing efforts have made clear that
the great majority of mammalian genes are subject to splice
variation, and that some genes show a very large number of
different transcript forms. One of the most basic questions to
ask about these splice variations is to what extent they are
regulated by the cell rather than being the result of noise in
the molecular process or of other fluctuations that are not
controlled by the cell. We investigated this issue for small
exon length variations caused by the alternative usage of
nearby acceptor and donor sites.
Small exon length variations are the second most common
form of splice variation. Among these, three-nucleotide
variations at tandem acceptor sites containing a NAGNAG
sequence pattern are by far the most common. It has been
Figure 7. Dependency of the Frequency of Alternative Splicing at
NAGNAG Sites on the Relative Likelihood of the Two Putative Acceptor
Sites
The figure shows the fraction of all NAGNAG boundaries that splice only
at the first NAG (red), only at the second NAG (green), or at both NAGs
(blue) as a function of the log-likelihood difference of the first and
second putative splice sites for the acceptor site WM.
DOI: 10.1371/journal.pgen.0020045.g007
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suggested that cells can ‘‘fine-tune’’ the expression of protein
forms through these subtle splice variations [20]. However, we
were unable to find any evidence that NAGNAG sites are
either under specific evolutionary selection or are more
abundant at coding exons than at noncoding exons. In
contrast, we collected and compared a number of statistics on
observed small exon length variations, and showed that all
these statistics can be accurately explained by the combined
effect of NMD and the stochastic binding of the splicing
machinery to competing nearby splice sites.
Our analysis of the relative abundances of exon length
variations of five and more nucleotides at donor and acceptor
sites of CDS, UTR, and noncoding exons strongly suggests
that NMD targets about 50% of frame-shifting exon length
variations at CDS exons. This effect partly explains the
overrepresentation of three-nucleotide variations in the data.
When the effects of NMD are taken into account, donor and
acceptor sites show very distinct relative abundances of small
exon length variations, with an overrepresentation of shifts of
length one and four at donor sites, and an overrepresentation
of shifts of length three at acceptor sites. However, shifts of
length three at acceptor sites are not more abundant at CDS
exons than they are at UTR and noncoding exons. This
observation again supports our conjecture that the abun-
dance of three-nucleotide shifts is special to the specifics of
splicing at acceptor sites and is not related to the coding
potential of the exon.
To explain the relative abundances of these small exon
length variations we introduced a model that assumes that the
last step in splice site selection involves the sequence-specific
binding of the splicing machinery to a splice site and that the
probability of splicing occurring at a particular site is
proportional to the affinity of the splice site sequence for
the splicing machinery. In this model, small exon length
variations can occur when there are multiple binding sites
with comparable affinity near each other. Our model is similar
to the scanning model proposed by Smith et al. [27] for the
selection of 39 splice sites: the spliceosome recognizes and
binds the region of the branch point and polypyrimidine
sequence, but once there, it can still ‘‘see’’ a limited stretch of
sequence in which competing splice sites may be present. The
relative frequencies with which these competing splice sites
are used in the splicing reaction are determined by the affinity
of the spliceosome for the sequences of the different sites.
From the splice sites of invariant exons we constructedWMs
representing the sequence specificity of the splicing machi-
nery at donor and acceptor sites. We used these WMs to
predict the relative frequencies of small exon length varia-
tions from the sequences flanking the observed splice sites of
variant exons and found that the predictions accurately
reproduce the observed relative abundances. For example, the
relatively high abundance of shifts of four nucleotides at
donor sites is explained by the common occurrence of a GT
pattern at positionþ5 of the intron [13,28]. The relatively high
abundance of three-nucleotide variations at acceptor splice
sites is explained by the fact that the WM of the acceptor sites
strongly disfavors a guanine at position3 (directly upstream
of the AG) and that positions5,6, and further upstream are
part of the polypyrimidine tract that disfavors the occurrence
of purines in general. Therefore, whenever an alternative AG
dinucleotide does occur, it is almost always at position3 and
not at1,2, or4.
Apart from explaining the relative abundances of small
exon length variations at both donor and acceptor sites, our
simple model also predicts, with reasonable accuracy, which
NAGNAG acceptor sites show splice variation and which do
not. We showed that when one of the two neighboring sites
has much higher affinity than the other, one observes splicing
almost exclusively at the site with the higher affinity. When
the neighboring sites have similar affinity, three-nucleotide
variations are observed in the large majority of cases.
Materials and Methods
Transcript mapping and splice analysis. The transcripts used in the
study consist of the 102,797 FANTOM3 mouse full-length cDNAs [29]
and 52,070 GenBank mouse mRNAs. We mapped all these transcripts
to the mm5 assembly of the mouse genome available from the
University of California Santa Cruz.
For the identification of splice variants we used a new implemen-
tation of the automated splicing analysis pipeline that we developed
for the FANTOM2 project [13]. Briefly, we first mapped all cDNAs to
the mouse genome using our novel spliced alignment algorithm, SPA
[30], which produces better quality alignments than other commonly
used cDNA-to-genome alignment programs. In particular, it has
fewer alignment errors around splice boundaries, and has a better
coverage of the 59 and 39 ends of the cDNAs. The details of the
comparisons of SPA’s mappings to those of other methods are
described in van Nimwegen et al. [30].
To avoid biases from transcripts that are badly mapped we selected
only those transcripts that had at least 75% of their nucleotides
mapped to the genome, with at least 95% identity or fewer than ten
mismatches in each exon. This procedure yielded 129,655 mapped
transcripts, which we clustered such that the mapping of each
transcript in a cluster shared at least one exonic nucleotide on the
same strand with at least one other transcript in the cluster [11,13].
We obtained 42,023 clusters (transcription units) that we analyzed for
splice variation. We refer the reader to Zavolan et al. [13] for the
details of the annotation procedure. Briefly, all exons whose genomic
mappings overlap were clustered into ‘‘genomic exons.’’ For each
genomic exon we then compared the set of exons corresponding to it
to identify splice variation.
For our analysis of exon length variations we extracted all genomic
exons that show only variation at their donor splice site and all exons
that show only variation at their acceptor splice site. For each such
genomic exon we then extracted the set of all ‘‘clean’’ exons
corresponding to it. These ‘‘clean’’ exons were selected based on
the following criteria: (1) the first and last ten nucleotides of every
clean exon must be perfectly aligned (no mismatches or gaps) to the
genome, and (2) the first ten nucleotides of the flanking exon(s) must
be perfectly aligned. We used the FANTOM3 and GenBank
annotation of CDSs to separate the exon boundaries of the clean
exons into boundaries that overlap with the CDS, boundaries that are
located in the UTRs of transcripts that have a CDS annotated, and
boundaries of exons from noncoding transcription units. A non-
coding transcription unit has no CDS annotated for any of its
corresponding transcripts.
For each genomic exon with variation only at the acceptor site or
only at the donor site we then determined the number of times each
alternative boundary was observed and took the most abundant
boundary as the ‘‘reference boundary.’’ We then counted the total
number of times other boundaries were observed for each of these
exons, and recorded the distances of these alternative boundaries
from the reference boundary. Finally, we constructed from these
counts the histograms of the number of observed exon length
variations as a function of the distance to the reference boundary for
each boundary type and each class of exon. The total numbers of
observed exon length variations for donor sites were 871 in CDS
exons, 524 in UTR exons, and 117 in noncoding exons, and for
acceptor sites were 1,620 in CDS exons, 366 in UTR exons, and 109 in
noncoding exons.
The relatively low number of variations in noncoding exons is a
result of the fact that transcripts from noncoding transcription units
in general have far fewer exons than do coding transcripts. In
addition, there are many transcripts for which no CDS is annotated
but that occur in a transcription unit that does contain at least one
transcript with an annotated CDS. We exclude these transcripts
because it is unclear whether they are indeed noncoding or whether
their CDS has simply not been annotated.
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For every exon that has variation only at its acceptor boundary we
collectedall transcripts that contain this exonandextracted thefirst 100
intronic nucleotides upstream of the acceptor site for this exon.
Similarly, for every exon with variation only at its donor boundary we
collectedall transcripts that contain this exonandextracted thefirst 100
nucleotides downstream of the donor site in each of these transcripts.
Selection of the sequences used for constructing the WMs for
donor and acceptor splice sites.We used the full set of clean invariant
exons to extract sequences at the acceptor and donor splice sites. We
removed all sequences that contained ambiguous characters and
obtained a set of 130,827 sequences in each set. We wanted to use the
sequences of these invariant exons to construct WMs for the acceptor
and donor site sequences. However, since we also wanted to score
NAGNAG sites for these WMs, we split the set of all invariant exons
into two halves and used only the first half to construct the WMs of the
six intronic and six exonic nucleotides flanking the splice site. The
other half we used for extracting NAGNAG sites of invariant exons.
Extraction of NAGNAG acceptor splice sites and log-likelihood
histogram. From the second half of acceptor site sequences of
invariant exons just described we collected all boundaries that have a
NAGNAG sequence. There were 2,444 cases of NAGNAG invariant
exons that splice at the first NAG and 228 cases of NAGNAG
invariant exons that splice at the second NAG. The set of variant
exons with NAGNAG sites consisted of all clean exons that contain a
NAGNAG motif at their acceptor site and whose only splice variation
involves the use of alternative acceptor sites precisely at the
NAGNAG boundary. We obtained 404 exons with such variant
NAGNAG acceptor sites.
For each of these NAGNAG sites we calculated the difference in
log-likelihood of the tandem putative acceptor sites for the acceptor
site WM. We then ordered all 3,076 NAGNAG sites by the log-
likelihood difference (from small to large) and calculated the average
log-likelihood difference and fraction of sites variant, invariant
splicing at the first NAG, and invariant splicing at the second NAG in
consecutive groups of 50 sites. That is, the horizontal value of the
leftmost data points of the red, green, and blue curves in Figure 7
were obtained by averaging the log-likelihood differences of the first
50 NAGNAG sites, and the vertical values were obtained by
calculating the fraction of variant NAGNAG sites (blue), invariant
NAGNAG sites splicing at the first boundary (red), and invariant
NAGNAG sites splicing at the second boundary (green) among those
first 50 NAGNAG sites. Similarly, the second leftmost set of data
points was obtained by calculating the same averages and fractions
over NAGNAG sites 11 through 60, the third set of points over
NAGNAG sites 21 through 70, etc.
Supporting Information
Table S1. The Relative Frequencies and Two Standard Errors of Exon
Length Variations of Length 1–4 at Donor and Acceptor Sites of
Different Exon Types
Note that, in order to correct for NMD, the number of variations of
length three has been multiplied by 0.53 and rounded to the nearest
integer.
Found at DOI: 10.1371/journal.pgen.0020045.st001 (11 KB PDF).
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Abstract
High-throughput sequencing studies revealed that the majority of human and mouse multi-exon genes
have multiple splice forms. High-density oligonucleotide array-based measurements have further estab-
lished that many exons are expressed in a tissue-specific manner. The mechanisms underlying the
tissue-dependent expression of most alternative exons remain, however, to be understood. In this study,
we focus on one possible mechanism, namely the coupling of (tissue specific) transcription regulation
with alternative splicing. We analyzed the FANTOM3 and H-Invitational datasets of full-length mouse
and human cDNAs, respectively, and found that in transcription units with multiple start sites, the
inclusion of at least 15% and possibly up to 30% of the ‘cassette’ exons correlates with the use of specific
transcription start sites (TSS). The vast majority of TSS-associated exons are conserved between human
and mouse, yet the conservation is weaker when compared with TSS-independent exons. Additionally,
the currently available data only support a weak correlation between the probabilities of TSS association
of orthologous exons. Our analysis thus suggests frequent coupling of transcriptional and splicing
programs, and provides a large dataset of exons on which the molecular basis of this coupling can be
further studied.
Key words: alternative splicing; transcription initiation
1. Introduction
The most common form of splice variation is the
inclusion of an exon in some, but not all, of the tran-
scripts of a gene.1,2 Numerous studies have been
dedicated to specific instances of such exons, which
are known by various names such as ‘cassette’, ‘alterna-
tive’, ‘skipped’, and ‘cryptic’ exons. The regulatory
signals leading to the inclusion orexclusion of a cassette
exon also form a vast topic of research. Computational
studies are converging toward the view that cassette
exons are generally less recognizable to the splicing
machinery than constitutive exons due to their
shorter length,3 lower strength of splice sites,4 and
poor representation of general splice enhancers,1,5
The tissue-specific inclusion of these exons appears to
be dependent upon specific regulatory elements,
at least some of which are located in the strongly
conserved intronic regions that flank the cassette
exons.2,6–8
One attractive hypothesis concerning the mechan-
ism of tissue-specific inclusion of cassette exons
involves the direct coupling between tissue-dependent
transcription and splicing. It has been shown, for
instance, that the promoter from which transcription is
initiated can affect the inclusion of downstream exons
through the recruitment of transcription factors and
co-activators that modulate the elongation rate
of RNA polymerase II9,10 (kinetic model). In turn, a
low polymerase elongation rate can promote the
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inclusion of some exons that are skipped when the
elongation rate is high, as has been shown for the
fibronectin EDI exon.11 Alternatively, protein factors
that are recruited at the stage of transcription
initiation may interact with splicing factors (recruit-
ment model). For instance, the inclusion of the fibro-
nectin EDII exon, normally promoted by the SRp40
protein,12 is inhibited when transcription is initiated
at a promoter containing a binding site for the
PPARg transcription factor. This is because the PPARg
transcription factor recruits an SRp40 inhibitor,
the PGC-1 co-activator.13 The role of the promoter
architecture on internal splicing has also been
demonstrated for the cystic fibrosis transmembrane
regulator14 and for the steroid-sensitive genes.15
Such studies have been limited, however, to very few
genes, prompting us to evaluate the extent to which
transcriptional and splicing programs appear to be
coordinated at the level of the whole transcriptome.
2. Materials and methods
2.1. Transcript mapping and splice analysis
The sequences used in the study consist of the
102 797 Fantom3 mouse cDNAs,16 52 070 mouse
mRNAs from Genbank, and 167 992 human cDNAs
from version 3.0 (http://www.h-invitational.jp/) of
the H-Invitational project.17 We have mapped the
mouse cDNAs to the mm7 assembly of the mouse
genome and the human cDNAs to the hg18 assembly
of the human genome, both available from the
University of California at Santa Cruz.
For the identification of splice variants, we used the
automated splicing analysis pipeline that we have pre-
viously developed.1,18 Briefly, we first mapped all
cDNAs to their respective genome using our spliced
alignment algorithm (SPA).19 To avoid biases from
transcripts that are badly mapped due to a high rate
of sequencing errors or erroneous assembly, we
select only those transcripts that have at least 75%
of their nucleotides mapped to the genome, with at
least 95% identity or less than ten mismatches in
each exon. This procedure yielded 132 681 mouse
and 110 978 human mapped transcripts, which
we clustered such that the mapping of each transcript
in a cluster shares at least one exonic nucleotide with
at least one other transcript in the cluster.1,18,20 We
obtained 42 407 mouse and 22 116 human clusters
(transcription units) that we analyzed for splice vari-
ation. We were interested only in cassette exons with
no other form of splice variation. We identified these
as internal exons that were completely contained in
an intron implied by the mapping of another
transcript in the cluster, having the same splice
boundaries in all transcripts in which they were
included. Our final mouse dataset consisted of
29 416 transcripts and 4 964 internal cassette
exons, and the human dataset of 79 030 transcripts
and 11 664 internal cassette exons.
2.2. Quantifying the evidence for coupling between
the choice of transcription start sites and
the inclusion/exclusion of internal exons
For each transcription unit, we first identified
(1) the set of internal cassette exons and (2) the set
of transcription start sites (TSSs). The cassette exon
annotation was determined as outlined above. To
identify different TSSs used within a transcription
unit, we had to define precisely what we mean by a
unique TSS. The analysis of mammalian TSSs by
Carninci et al.21 has shown that most TSSs show
some amount of variability. Especially at TSSs located
in CpG islands, one finds transcripts starting from
many different nearby sites covering tens and some-
times hundreds of nucleotides. We, therefore, needed
to group transcripts whose apparent start sites were
‘near’ each other and then identify different TSSs
with the different clusters of apparent start sites. We
decided to take a conservative approach to this clus-
tering of apparent start sites in a transcription unit
by considering all transcripts that started within the
same exon to derive from the same TSS. That is,
in our analysis different TSSs correspond to different
initial exons in the transcripts.
In addition, we tested the validity of our results, on a
separate dataset in which we use only transcripts
whose initial exons were confirmed by CAGE tag
data.22 In the latter case, the initial exon was
considered confirmed as a TSS if one or more CAGE
tags were found within 100 bp of the start of the
exon in the genome. Since the results did not
change, and the requirement of CAGE validation of
TSSs reduced the size of our data-set significantly,
we did not use the CAGE validated TSSs further.
For each internal cassette exon, we collected all
transcripts that could have included the exon as an
internal exon, i.e. those transcripts that contained
exons both upstream and downstream of the
genomic location of the exon in question, and deter-
mined the TSS that was used for each of these tran-
scripts. We thus obtained a list of TSSs that were
used in the set of transcripts in which the cassette
exon could have been included. For further analyses,
we kept only cassette exons for which multiple TSSs
were identified. We then counted, for each TSS in
the list, how many transcripts starting from this TSS
included the exon, and how many transcripts
excluded the exon. For each internal exon, we thus
obtained counts of the number of times each TSS
was used in a transcript whose locus covered the
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exon, and the number of times the exon was included
and excluded with each of the TSSs.
To identify exons whose inclusion depends on
which TSS was used, we used a Bayesian model selec-
tion procedure that compared the probabilities of the
observed counts under a TSS-independent model and
a TSS-dependent model. Considering a particular
cassette exon, let ti denote the total number of
times TSS i was used, ni the number of times the
exon was included when TSS i was used, t the total
number of transcripts, and n the total number of
times that the exon was included. For the indepen-
dent model, we assumed that the n inclusions are dis-
tributed at random among the t transcripts. Under
this model, the probability of the observed counts
fnig, given the counts ftig, and n is
Pindepðfnigjn; ftigÞ ¼
n!ðt nÞ!
t!
Y
i
ti!
ni!ðti  niÞ!
: ð1Þ
For the dependent model, we assumed that the rates
of inclusion and exclusion for the different TSSs are set
by some unknown mechanism. Given our general
ignorance about the mechanism or mechanisms
determining these rates, there is no reason to
assume that any set of counts fnig is more or less
likely than any other set of counts. We, therefore,
assumed that all possible counts fnig that are consist-
ent with the totals ftig and the total number of
inclusions n are all equally likely, meaning that
Pdepðfnigjn; ftigÞ ¼
1
Cðn; ftigÞ
; ð2Þ
where C(n, ftig) is the total number of different sets of
counts fnig that are possible, given the totals n and
ftig. The total count numbers C(n, ftig) can be deter-
mined recursively. Let Ci(r) be the number of different
inclusion counts n1 through ni that can be assigned to
TSSs 1 through i, such that r of the n total inclusions
remain. We have the following recursion relation for
Ci(r):
CiðrÞ ¼
Xti
ni¼0
Ci1ðr þ niÞ: ð3Þ
We initialize the recursion by setting
C0ðrÞ ¼ drn; ð4Þ
that is, before we assign counts to any TSS there have
to be precisely n inclusions left. Once we arrive at the
last (pth) TSS, our count C(n, ftig) is given by Cp(0), i.e.
there should be no inclusions left.
To estimate the total fraction f of cassette internal
exons whose inclusion is dependent on TSSs, we calcu-
lated the probability P(Djf ) of the data of all cassette
exons assuming that a fraction f was dependent. Let
Pindep(k) and Pdep(k) denote the probabilities of the
counts for the kth cassette exon given the indepen-
dent and dependent model, respectively. For each
exon k, these quantities are computed according to
Equations (1) and (2). We then have
PðDjfÞ ¼
Y
k
PindepðkÞð1 fÞ þ PdepðkÞf
 
: ð5Þ
Using a uniform prior over f the posterior prob-
ability P( fjD) for the fraction of dependent exons
given the data simply becomes
Pð f jDÞ ¼ PðDjfÞÐ
PðDj~fÞd~f
: ð6Þ
This distribution is shown as the solid line in Fig. 2.
We calculated the expectation value kfl ¼ Ð f P( f j D)
Figure 1. Example of an internal cassette exon whose inclusion
is strongly correlated with specific TSSs. Exons are indicated by
(green) boxes and introns by red lines. Cassette exons are
shown with a black frame. The internal cassette exon that has
a high probability of TSS association is indicated by the thin
black rectangle. The number of times a specific TSS-splicing
pattern was observed in the data is indicated by the
multiplicity on the right. For simplicity, we show only those
transcripts whose genomic locus contains the cassette
exon, and we truncate the first three transcripts past the
TSS-associated cassette exon. Table 1 summarizes the data
in the figure, indicating how many times the exon was
included and how many times skipped when a particular TSS
was used.
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df and using kfl as a prior probability of the indepen-
dent model we computed, for each individual exon,
the posterior probability that the inclusion of the
exon is TSS associated.
We also generated a randomized dataset Drand by,
for each exon, randomly distributing the n inclusions
of the exon among the different TSSs, in such a way
that the total number of transcripts ti for each TSS i
stays the same. That is, the data Drand were generated
in accordance with the independent model, keeping
the total inclusion counts n, and total TSS counts
ftig of the real data. The distribution P( fjDrand) is
shown as the dotted line in Fig. 2.
2.3. Extraction of constitutive exons
We used our database to identify internal exons
that were included in more than ten transcripts and
did not have any splice variation. We obtained 5136
and 6377 such exons for mouse and human, respect-
ively, and we used these as internal constitutive exons.
2.4. Computation of the exon conservation statistics
We used the whole-genome alignments provided by
the University of California, at Santa Cruz (http://
hgdownload.cse.ucsc.edu/goldenPath/mm7/vsHg18/
axtNet/ and http://hgdownload.cse.ucsc.edu/golden
Path/hg18/vsmm7/axtNet/) to extract alignments
of mouse exons in our dataset with the correspond-
ing orthologous regions from the human genome,
and of human exons with the corresponding ortholo-
gous regions from the mouse genome. We found
orthologous human regions for 438 of the 496 TSS-
associated, 469 of the 496 TSS-independent, and
5122 of the 5136 constitutive internal mouse
exons. Similarly, we found orthologous mouse
regions for 1003 of the 1166 TSS-associated, 1078
of the 1166 TSS-independent, and 6344 of the
6377 constitutive internal human exons. On the
basis of the extracted alignments, we determined
the fraction of all mouse exon nucleotides that are
perfectly conserved in human, and the fraction of
human exon nucleotides that are conserved in mouse.
To compute the correlation between posterior
probabilities of TSS association in human and
mouse, we used the following procedure. We started
with cassette exons from transcription units with mul-
tiple TSSs from human. On the basis of the whole-
enome alignments, we found the orthologous
mouse exons as described above, and then we inter-
sected the coordinates of these orthologs with the
coordinates of mouse cassette exons that were part
of transcription units with multiple TSSs. This pro-
cedure gave us the list of orthologous cassette exons
that were part of transcription units with multiple
TSSs in both human and mouse. We checked that
we obtain the same list of exons if we start from the
mouse cassette exons and compute their human
orthologs. We did not set a threshold of minimal con-
servation between orthologous exons, as the dataset is
already relatively small, and our previous results were
not sensitive to the precise threshold of conservation
that we used.
2.5. Computation of the average distance to
an inclusion-promoting TSS and to
a skipping-promoting TSS
We identified all transcripts in which a particular
cassette exon was included, and for each of them,
we determined the distance in the genome between
the TSS and the start of the cassette exon. We then
averaged these distances to obtain the average dis-
tance of the exon to an inclusion-promoting TSS.
Similarly, we identified all transcripts in which a par-
ticular cassette exon was skipped, and we computed
the average distance of the exon to a skipping-
promoting TSS.
Figure 2. The posterior probability P( fjD) that the inclusion of
cassette exons is dependent on the TSS in a fraction f of all
cassette exons (solid line). The dashed line shows the same
distribution P( fjDrand) for a randomized dataset containing the
same marginal counts of inclusion and TSS usage for each
exon. The upper panel shows the human data, and the lower
panel the mouse data.
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2.6. Analysis of 50 EST data
To address the issue of biases in the coverage of
gene structures that may have been introduced by
the selection of clones for full-length cDNA sequen-
cing, we have performed the same analysis using
only 50 EST sequences. On the basis of the October
2007 UniGene database, we extracted 3 738 929
human 50 EST sequences. We removed from this set
those ESTs with low sequence quality (over 3% ambig-
uous nucleotides), we then trimmed the polyA tails
and discarded those ESTs whose length was ,95
after polyA tail removal (using the trimpoly program
of the SeqClean package from http://compbio.dfci.
harvard.edu/tgi/software/). We thus obtained
3 700 028 ESTs, which we mapped to the hg18
assembly of the human genome using our SPA
program.19 After mapping, we retained for further
analysis only ESTs, which contained at least two
exons, were mapped with overall 95% identity, and
whose every exon was mapped with at least 98%
identity to the human genome. This selection left
1 276 669 good quality ESTs, which we clustered
based on exon overlap and annotated for splice vari-
ation as described in Section 2.1.
3. Results and discussion
3.1. The inclusion/skipping of internal exons is
correlated with the usage of specific TSSs
We used a Bayesian approach to estimate the frac-
tion f of internal cassette exons whose inclusion
depends on the choice of TSS. We thus considered
two models: the first assumes that the probability of
exon inclusion is independent of the TSS used to tran-
scribe the pre-mRNA, i.e. the probability of exon
inclusion is the same for all TSSs, and the second
assumes that for each TSS there is an independent
probability of exon inclusion, which can be different
between different TSSs. For a given f, we can write
the probability of the data as
PðDjfÞ ¼
Y
k[exons
PindepðkÞð1 fÞ þ PdepðkÞf
 
; ð7Þ
with Pdep(k) and Pindep(k) being the probabilities of
the data for cassette exon k under the dependent
and independent models, respectively. In order to
obtain these probabilities we collected, for each
internal exon, the set of transcripts in the dataset
that could have contained the exon, i.e. those tran-
scripts that contain exons both upstream and down-
stream of the genomic location of the cassette exon
in question. We divided this set of transcripts into
groups that use the same TSSs, and counted the
number of transcripts in which the exon was included,
and the number of transcripts in which the exon was
excluded in each TSS group. A specific example of this
computation is shown in Fig. 1.
As described in Section 2.2, we can use Equation (7)
and Bayes’ theorem to calculate the posterior prob-
ability P( fjD) that a fraction f of all cassette exons is
dependent on the TSS. The distributions P( fjD)
obtained for both the human and mouse data are
shown as solid lines in Fig. 2. They suggest that the
inclusion of about 24% (99% posterior probability
interval 17.4–30.6%) of all cassette exons in our
mouse dataset and 30% (99% posterior probability
interval 26.2–34.9%) of all cassette exons in our
human dataset is dependent on the TSSs of the corre-
sponding transcripts. To additionally test the statisti-
cal significance of this result, we created randomized
datasets Drand by permuting, for each cassette exon,
the inclusions and exclusions among the TSSs in
such a way that the total number of times each TSS
was used, and the total number of times the exon
was included remained unchanged. The posterior
distributions P( fjDrand) obtained by applying the
Bayesian procedure to the randomized data are
shown as dashed lines in Fig. 2. These distributions
show that the Bayesian procedure correctly infers
that the inclusion of ,5% (and likely none) of the cas-
sette exons in Drand depends on TSS. Moreover, Fig. 2
shows the striking difference between the real and
randomized data, which is due to the enrichment of
cassette exons with high posterior probability of TSS
dependency in the real data.
Using the estimated fraction kfl (the mean of the
posterior distribution P( f jD)) as a prior that the
inclusion of a cassette exon depends on TSS, we
computed the posterior probability that the inclusion
of each exon in our dataset is TSS dependent
(see Section 2.2). These data are given in the
Supplementary table, and can also be further explored
using the server that we established at http://www.
spaed.unibas.ch/Promoter_data/TSS_cassette_exons_
spaed_human.html and http://www.spaed.unibas.ch/
Promoter_data/TSS_cassette_exons_spaed_mouse.
html.
Fig. 1 shows the cassette exon with the highest pos-
terior probability of TSS dependence in our mouse
data. The exon belongs to the gene aspartate beta
hydrolase has a posterior probability of TSS depen-
dency of 0.89, and is indicated in the figure by the
thin black rectangle. For clarity, we showed only the
transcripts whose genomic loci contain the cassette
exon, and we also truncated some of the transcripts
after the exon in question. There are three different
TSSs upstream of the exon, and a total of 23 tran-
scripts that could have included this exon. Of the 11
transcripts originating in the two upstream TSSs,
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only one includes the cassette exon. In contrast, nine
of the 12 transcripts originating from the third TSS
include the cassette exon.
One may wonder to what extent our results are
affected by imperfect efficiency of full length cDNA
capture. That is, if a significant fraction of the cDNAs
is not full length, the apparent TSSs for these tran-
scripts would be incorrect, and one may wonder
how they would influence our results. We have
addressed this question by performing the same
analysis using only transcripts whose start site was
confirmed by CAGE tag data,22 and obtained essen-
tially the same results. However, since requiring
additional confirmation of TSSs substantially reduces
the sizes of our datasets, we did not use this dataset
further.
It is important to note that we do not need to find
the precise locations of the TSSs which may in fact
be much less precise than initially thought,21 but we
only need to separate our transcripts into sets that
arose from the same transcription initiation regions,
controlled by specific sets of regulatory signals. We
decided to simply assume that transcripts with the
same initial exon arose from the same TSS and that
transcripts with different initial exons arose from
different TSSs. Two types of errors may occur in this
classification. First, transcripts that arose from two
different, but nearby TSSs may be assigned to a
single common TSS. Second, if a transcript is severely
truncated due to cloning or sequencing errors, it
may appear to start in an exon which is downstream
from its real initial exon. Since the first type of error
reduces our ability to distinguish different TSSs, and
the second error per definition must be uncorrelated
with splicing, the effect of both types of errors will be
to reduce the correlations between TSS usage and spli-
cing. Therefore, the clear correlations that we observe
in spite of these potential errors should be considered
to provide a lower bound on the correlations that
do exist.
Another concern may be that the gene structures
inferred from full-length cDNA are not representative,
because the full-length cDNA sequencing projects
generally included a prioritization step, that may
have caused an apparent enrichment in rare splice
variants. To address this issue, we have constructed a
database of splice variants using solely human 50-
end ESTs, which we obtained based on the UniGene
annotation. We analyzed these data using the same
model as we used for full-length cDNAs. The 99%
probability interval computed using this dataset
was 0.74–0.78, compared with 0–0.009 obtained
using the corresponding randomized dataset. This
indicates that TSS-associated splice events are in fact
even more frequent than initially estimated from
full-length cDNA data. The likely reason why the
estimate of the fraction of TSS-associated exons is
larger when using 50 EST data compared with full-
length cDNA data is illustrated in Fig. 3. The exon
indicated by the box belongs to the cAMP-dependent
protein kinase catalytic beta subunit (PRKACB), is
always skipped when the two upstream promoters
are used (136 ESTs), and is generally included with
the most downstream promoter (46 of 56 ESTs).
These counts are very unlikely under a model in
which the promoter usage and exon inclusion are
uncoupled. Generally, many exons that in the cDNA
data did not have sufficient coverage to allow us to
detect their TSS association do have sufficient cover-
age in the 50 EST data to allow this inference to be
made, and consequently, the fraction of exons
inferred to be TSS associated is larger.
3.2. Evolutionary conservation of TSS association
If the correlation that we inferred between tran-
scriptional and splicing events is functionally relevant,
one would expect that the TSS dependence tends to
be conserved between orthologous cassette exons.
This could, for instance, manifest itself in a correlation
of the posterior probabilities of TSS dependence of
orthologous cassette exons. To check this, we started
with the human and mouse cassette exons that are
part of transcription units with multiple start sites,
Figure 3. Example of an internal cassette exon whose inclusion is
strongly correlated with specific TSSs as inferred from 50 EST
data. The conventions used in this representation are the same
as for Fig. 1. Exons shown in green have invariant splice
boundaries, those in yellow have variable splice donor sites,
and those in cyan intron inclusion. The inclusion of the exon
indicated by the black box occurs only when the most
downstream TSSs are used.
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and we used the UCSC human-to-mouse and mouse-
to-human whole-genome alignments to identify
orthologous exons (see Section 2.4). This procedure
yielded 668 pairs of orthologs. We then computed
the correlation coefficient between the posterior
probabilities of orthologous exons. As shown in
Fig. 4 we obtained a weak, but significant (P ¼
0.002) correlation between the probabilities of TSS
association of orthologous exons, providing some
evidence that TSS dependence of exon inclusion is
evolutionarily conserved.
One of the best examples of an evolutionarily con-
served relationship is shown in Fig. 5. The exon with
a high probability of TSS association (P ¼ 1 in
human and P ¼ 0.73 in mouse) is indicated by an
arrow. It is included in the skeletal form of tropomyo-
sin, which uses the most upstream TSS, and is
excluded in other forms of tropomyosin, which also
tend to use downstream TSSs.
The level of evolutionary conservation of cassette
exons has previously been related to the rate of
inclusion of the exons in mature mRNAs: the so-
called ‘major form’ exons, which are predominantly
included, are as conserved as constitutive exons,
whereas ‘minor form’ exons, which are predominantly
skipped, appear to be of a more recent evolutionary
origin,23 rarely having orthologs between human
and rodents. To understand where TSS-associated
exons fit in this evolutionary scenario, we analyzed
the degree of human–mouse conservation of the
following categories of exons: (1) TSS-associated
exons—those with the top 10% values of posterior
probability of TSS association, (2) TSS-independent
exons—those with the bottom 10% values of posterior
probability of TSS association, and (3) constitutive
exons—exons included with no variation in more
than ten transcripts. For each of these exons, we
extracted the mouse—human and human–mouse
alignments from the whole genome alignments pro-
vided by the UCSC (see Section 2.4). We then com-
puted the fraction of exons that have orthologs in
the other species and the fraction of nucleotides in
each exon that are conserved. As shown in Table 1,
we found that the large majority of TSS-associated
exons are conserved between mouse and human
(438/496 ¼ 88.3% of mouse and 1003/1166 ¼
86.02% of human TSS-associated exons). Particularly,
TSS-associated exons are much more strongly con-
served than ‘minor form’ exons, only 27–31% of
which having been reported to be conserved
between human and rodents,23 However, TSS-associ-
ated exons are significantly less conserved than TSS-
independent exons (469/496 ¼ 94.6% in mouse and
1077/1166 ¼ 92.4% in human, P-value of the x2
test ¼ 6.7  1024 for mouse and 1.12  1026 for
human). These results are not sensitive to the precise
threshold beyond which we consider an exon ‘con-
served’. Among those TSS-associated exons that do
have orthologs, the proportion of conserved nucleo-
tides is lower compared with TSS-independent exons
(P-value: 2.9  10212 for human and 2.2  1023 for
mouse), as well as compared with constitutive exons
(P-value of the Wilcoxon test ,2.2  10216 for
human and 4.7  1022 for mouse). Consistent with
previous results relating the degree of evolutionary
conservation to the inclusion rate of the exons,23 we
found that the overall inclusion rate of TSS-associated
Figure 4. Correlation between the posterior probabilities of TSS
association for orthologous human–mouse cassette exons.
Each dot represents one exon, with the x-coordinate being the
posterior probability of TSS association of the human exon and
the y-coordinate being the the posterior probability of TSS
association of the orthologous mouse exon. The correlation
coefficient is r ¼ 0.12, P-value = 0.002.
Figure 5. Conserved TSS association for a tropomyosin exon. The
intron/exon structure of tropomyosin transcripts initiated from
various TSSs is shown, with exons represented as black boxes
and introns as red lines connecting the exons. The number of
times each transcript form was observed in our dataset is
indicated by the ‘multiplicity’ column on the right-hand side
of the transcripts. The orthologous cassette exons are indicated
by arrows, and their posterior probabilities of TSS association
are indicated.
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exons is lower than the inclusion rate of TSS-
independent exons (Table 1). Thus, the results
suggest that some of the TSS-associated exons are of
relatively recent evolutionary origin, and it will be
interesting to establish whether the TSSs that
promote their inclusion have also undergone recent
evolutionary changes. On the other hand, the rela-
tively weak correlation between the probabilities of
TSS association of orthologous exons is likely to be
in part due to the fact that the human and mouse
sequencing projects did not cover sufficiently similar
sets of tissues. This would be reflected in different
relative usage of the alternative TSSs and exons
between human and mouse and these, in turn,
would be reflected in disparate probabilities of TSS
association of orthologous exons in the two species.
Finally, we did not find a consistent trend in the pro-
portion of ‘symmetrical’ exons, i.e. the proportion of
exons whose length is a multiple of three, among
our different categories of exons. We did not specifi-
cally select the exons for being part of coding
regions, but rather we only considered internal
exons in our analysis. As shown in Table 1, the pro-
portion of symmetrical exons is significantly higher
than expected by chance, i.e. 1/3, for all exon types
(TSS-associated, TSS-independent, constitutive). In
human, TSS-associated exons have a significantly
higher tendency for symmetry compared with consti-
tutive internal exons (P-value of the x2 test ¼ 0.02),
and lower, but not significantly, compared with TSS-
independent exons (P-value of the x2 test ¼ 0.07).
The tendencies are similar in mouse, but the differ-
ences are not statistically significant (P-value of the
x2 test ¼ 0.36 in the comparison with constitutive
exons and 0.097 in the comparison with TSS-
independent exons).
3.3 Insights into the mechanism of coupling between
transcriptional and splicing events
We can envision two mechanisms that could give
rise to the correlation that we observe between
transcriptional and splicing events. One is that
tissue-specific transcriptional and splicing events are
induced by independent, but tissue-specific transcrip-
tion and splicing factors. The second mechanism
involves a direct influence of tissue-specific transcrip-
tion factors on internal splicing. We reasoned that if
an exon is always included when one TSS is used
and always skipped when another TSS is used, yet
the two TSSs are both used in the same tissue, then
the TSS association may be due to direct coupling of
transcription with exon selection. To identify such
cases, we used the library annotation of the tran-
scripts in our datasets. We found that for 21% of the
human and 14% of the mouse TSS-associated exons
the inclusion- and skipping-promoting TSS have
been both used in the same tissue.
One model that has been proposed for the coupling
between transcriptional and splicing events is known
as the ‘kinetic model’,10 which postulates that cas-
sette exons with weaker splice signals compared
with constitutive exons tend to be skipped when the
transcript is produced by a fast-elongating polymer-
ase. In contrast, when the polymerase elongation
rate is low, the spliceosome has sufficient time to
assemble on these cassette exons, which are then
spliced into the mature mRNA. We used a web
server implementing the Shapiro and Senapathy
model24 (http://ast.bioinfo.tau.ac.il/SpliceSiteFrame.
htm) to evaluate the strength of the splice sites of
the cassette exons as well as of the exons flanking
them. We found that the strength of the splice sites
is comparable between the cassette exons and the
exons flanking them (data not shown), suggesting
that one of the pre-requisites of the kinetic model
(weaker splice sites) is not met by our sets of TSS-
associated exons.
Given that the elongation rate is not homogeneous
along a gene, and that promoter-proximal pausing of
RNA polymerase II is common,25 we reasoned that
the elongation rate of the polymerasemay be generally
lower at the start of the transcripts, allowing better
recognition of cassette exons that are close to the TSS.
Therefore, we asked whether the TSS-associated
exons tend to be included when the TSS closest to
Table 1. Comparison of TSS associated, TSS independent, and constitutive exons
Data set Number exons With orthologs Median proportion conserved nucleotides Inclusion rate Proportion symmetrical
Human exons
TSS associated 1166 1003 0.84 0.75 0.41
TSS independent 1166 1077 0.87 0.86 0.45
Constitutive 6377 6343 0.88 1 0.38
Mouse exons
TSS associated 496 438 0.86 0.75 0.42
TSS independent 496 469 0.88 0.88 0.48
Constitutive 5136 5117 0.87 1 0.4
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them is used, as this may allow sufficient time for
spliceosome assembly. We found this not to be the
case: for all TSS-associated exons, we computed the
average distance Di between the exon and the TSSs
of transcripts that included the exon, and the
average distance Ds between the exon and the TSSs
of transcripts that excluded the exon. We then con-
structed a histogram of the difference Di 2 Ds across
cassette exons (Fig. 6). To improve visibility of the his-
togram, we split it into a part where Di2 Ds. 0 and a
part where Di2 Ds, 0, and plotted the absolute dis-
tance jDi2 Dsj on a logarithmic scale. We found that
approximately the same proportion of TSS-associated
exons are preferentially included with the most
upstream TSSs as are included with the most down-
stream TSSs (Fig. 6). This suggests that proximity to
the TSS, which may be indicative of lower polymerase
elongation rate, cannot explain the inclusion pattern
of TSS-associated cassette exons.
To conclude, we estimated that exons whose
inclusion in the mature mRNA is correlated with
specific TSSs are rather common, i.e. they represent
at least 15% of all internal cassette exons. The
correlation may be due to direct coupling between
transcription and splicing or indirect coupling, due,
for instance, to a tissue-specific signaling pathway
that activates both the transcription factors respon-
sible for determining the TSS as well as the splicing
factors responsible for the inclusion or exclusion of
the cassette exon. Nonetheless, for at least 14–21%
of the TSS-associated exons, TSSs that are associated
with exclusion and TSSs that are associated
with inclusion occur both in the same tissue,
suggesting a more direct connection between the
TSS and exon inclusion for at least these exons.
The details of the molecular mechanism underlying
this dependency remain to be uncovered, and may
involve a gene-specific component, as suggested by
our observation that some exons are predominantly
included when the proximal TSSs are used, while
other exons are predominantly skipped. One way of
implementing a gene-(and tissue-) specific com-
ponent could be through dynamic changes in the
local chromatin structure that induce in turn local
variations in the polymerase elongation rate.26 This
is a topic for future study and the cassette exons for
which we estimated a high probability of TSS associ-
ation provide good starting points for experimental
investigations.
Supplementary Data: Supplementary data are
available online at www.dnaresearch.oxfordjournals.org.
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